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EXECUTIVE SUMMARY
Greene, Denise. Addressing Adherence to Bisphosphonate Medication Using a SystemsBased Approach. Unpublished Doctor of Nursing Practice Capstone Project,
University of Northern Colorado, 2015.
Primary non-adherence (PNA) to bisphosphonate medications has been recently
identified to be as high as 30% in patients with osteoporosis or who are at risk for hip
fracture. It is known that taking a bisphosphonate is the main course of defense in
lowering patient risk and decreasing the hip fracture rate by 50%. However, if patients
do not take their medication, they will not receive the benefit of fracture risk reduction
that comes with it. This paper explored the testing and implementation of a protocol
designed to improve the PNA rate and thus improve patient outcomes. This protocol
used evidenced-based information that improved the provider-patient relationship
through a telephone outreach protocol aided by a computer system that identified patients
who had not picked up their medications from the pharmacy. The nurse practitioner (NP)
coordinator targeted each patient and then worked the list of patients at risk until all
patients had been contacted. The goal was to lower the PNA rate by 20% by targeting
those patients who had not picked up their medications and by changing their behavior to
develop an intention to pick up and take their bisphosphonate medication. This goal was
reached as the PNA rate was reduced to 3.2%, although it might have been a combination of
contributing factors that led to the decrease in rate and not the telephone outreach alone. The
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protocol was successful and was accepted into practice to be replicated throughout all of the
medical centers within the organization.
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CHAPTER I
INTRODUCTION
Statement and Background of the Problem
Major advancements in the pharmaceutical management of osteoporosis have
contributed to drastic reductions in osteoporosis and related fractures. Therapeutic results
of medication treatment for osteoporosis can reduce the risk of hip fracture by 47%
(Ensrud et al., 1997). The primary treatment of choice for osteoporosis is a class of
medications called bisphosphonates. Evidence has shown that patients could have up to a
50% reduction in their fracture risk if this medication is taken properly (Black et al.,
2000). The impact of osteoporosis related fractures is significant in terms of poor
outcomes for the patient as well as being tremendously costly to the healthcare system.
Medication adherence is essential for reducing morbidity and mortality in patients with or
at risk for osteoporosis. Accomplishing medication adherence requires a system of care
that addresses the individual needs of patients with osteoporosis and provides a method
for tracking patient data through information technology to identify non-adherence.
Combining these into a model of care that provides strategies targeting adherence at both
the individual and systems levels is needed to reduce osteoporosis-related fractures with
decreased morbidity and mortality in this population. While strategies are needed at both
levels to positively impact outcomes of patients with osteoporosis, efforts to accomplish
this have met with limited success.
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Management of osteoporosis, as with any chronic disease, is based on the ability
of health care providers to (a) identify patients at risk for fractures and (b) implement
evidence-based treatment regimens that will lead to improved patient outcomes, thereby
reducing morbidity and mortality. Improved patient outcomes can only occur if patients
adhere to treatment. While adherence to treatment can occur at many levels, primary
non-adherence (PNA) occurs when patients do not pick up their prescriptions within 60
days of receiving the prescription (Reynolds et al., 2013). Utilizing information
technology at the system level to identify those patients who are non-adherent in
obtaining their medication is one method of alleviating non-adherence and potentially
impacting outcomes.
This project focused on answering the following research question:
Q1

Will a telephone outreach protocol based on the theory of planned
behavior (TPB) be effective in lowering the primary non-adherence rate
(PNA) to bisphosphonate medication by 20% in a large Health
Maintenance Organization (HMO)?

Thus, a protocol designed to increase patient adherence in taking medications was
implemented and evaluated in a practice setting. The project included data analysis to
monitor the activities of patients who had a new prescription for a bisphosphonate and
whether or not they picked the prescription up from the pharmacy within 60 days. The
project investigated whether a protocol that included individual nurse practitioner (NP)
and system strategies could impact primary non-adherence in patients at risk for or who
have osteoporosis.
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Population/Intervention/Comparison/
Outcome/Time Statement
Population/Intervention/Comparison/Outcome/Time (PICOT) is the method used
in addressing clinical questions related to PNA. According to Melnyk and FineoutOverholt (2011), the components of a PICOT question include patient population,
intervention, outcome, and timeline to goal completion. The population for this project
included men and women over the age of 55 years with primary non-adherence to
bisphosphonate medication. The PICOT question answered in this paper was as follows:
Will the implementation of a practice protocol impact patient primary non-adherence
(PNA) within 60 days of a new bisphosphonate prescription? As part of an osteoporosis
disease management program, NP specialists in osteoporosis disease management
utilized a protocol that focused on interventions to address and improve the rate of PNA.
Background and Significance of the Problem
This section begins with a brief description and definition of terms unique to and
used consistently throughout this paper.
Definitions
The National Osteoporosis Foundation (NOF; 2013b) defines osteoporosis as a
disease characterized by low bone mass and structural deterioration of bone tissue,
leading to bone fragility and an increased risk of fractures, especially of the hip.
Osteoporosis is known as a silent disease because bone loss can occur without symptoms
until a fracture event occurs, making the condition more challenging to prevent and treat
(NOF, 2013a). To date, bisphosphonates are proven to be the best medication to treat
osteoporosis and prevent subsequent fractures (Black et al., 2000).
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Primary non-adherence (PNA) of a bisphosphonate occurs when patients do not
retrieve their new prescription from the pharmacy within 60 days of the date of the
prescription. This is also referred to as non-fulfillment. Secondary non- adherence
(SNA) describes non-persistence of a medication and occurs when the patient fails to
refill their medication from the pharmacy after it was initially filled. This definition of
secondary non-adherence was included because it is important to understand both of the
concepts of primary and secondary non-adherence; only PNA was followed for the
purpose of this paper.
The Knowledge Builder Tool is an information technology (IT) tool embedded
into the electronic medical record (EMR) that assists the nurse practitioner (NP) in
identifying patients who are not picking up their bisphosphonate medications from the
pharmacy. The NP then monitors the treatment to meet program hip fracture reduction
goals based on national guidelines established by the National Osteoporosis Foundation
(2013a).
Statement of the Problem
Each year in the United States, two million people have an osteoporosis-related
fracture. Of these fractures, 300,000 are hip fractures--the most serious of all fractures.
Primary non-adherence is a major problem in the treatment of patients with osteoporosis.
Reynolds et al. (2013) stated that 29.5% of patients in a large health care organization
who were prescribed a bisphosphonate for osteoporosis did not pick up the medication,
take it, or gain any benefit from it. Other authors have also shown both PNA and SNA to
be a problem in the treatment of osteoporosis; this is discussed further in the literature
review section of this paper.
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In clinical trials, the use of bisphosphonate treatment has led to a 50% reduction
in hip fractures (Black et al., 2000). When not taken correctly, the rate of hip fracture
increases (Silverman & Gold 2008; Siris et al., 2006). No intervention other than
medication adherence has shown this level of success in hip fracture reduction (Siris et
al., 2006). Solutions to addressing this barrier are needed to improve treatment rates and
patient outcomes. Although clinical and evidence-based guidelines are available to guide
treatment, high rates of fractures continue, perhaps due to difficulties in primary nonadherence of patients who have been prescribed bisphosphonate anti-osteoporosis
medications.
The significance of PNA spans three levels: the individual patient, the provider,
and the system. All three contribute differently to the outcome of PNA and adherence to
bisphosphonate medications. Even though health care providers have access to clinical
care guidelines, there is no assurance they are followed in managing care of patients.
Historically, published guidelines alone have generally been ineffective in changing
provider behavior (Grol & Grimshaw, 2003). In fact, many factors related to knowledge,
attitudes, and behaviors contribute to a stagnation in implementation of guidelines.
Cabana et al. (1999) described six barriers: (a) lack of awareness or familiarity with the
desired change, (b) disagreement with specific guidelines or guidelines in general, (c)
doubt that following the guideline will lead to desired outcomes, (d) an inability to
overcome existing practice habits, (e) patient factors such as preferences, and (f)
environmental factors such as lack of time or resources.
Problem at patient level. Even when there is a system in place for early
identification and treatment of patients at risk for a hip fracture, if the patient does not
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pick the medication up from the pharmacy, they will not benefit from the medication's
fracture reducing action (Silverman, Schousboe, & Gold, 2011). Silverman et al. (2011)
identified that patients are not always truthful when asked to self-report the reasons for
not picking up or taking their medications. Often times, they report that they simply
forgot. It is also known that patient decisions to take or not to take medications might be
transient and could change with time (Sale et al, 2011). Patients who do not pick up their
medications from the pharmacy have made a conscious choice not to do so for many
different reasons (Silverman et al., 2011).
Problem at provider level. The provider has a responsibility in PNA as well as
the patient and the system itself. Lack of communication on the part of the provider
regarding the diagnosis and the need for medication contributes to non-adherence. If a
patient is prescribed a bisphosphonate and the provider does not actually diagnose the
patient with osteoporosis by dual energy X-ray absorptiometry (DXA) or other means
and does not discuss the diagnosis with the patient, this decreases the likelihood the
patient will actually take the medication (Giangregorio et al., 2008). Without a diagnosis
or discussion about his/her individual fracture risk and the importance of the medication,
the patient may not be aware of the necessity to take the medication (Giangregorio et al.,
2008). Since osteoporosis is usually asymptomatic until the fracture event, the patient is
less likely to take the medication; more likely, he/she will take a medication to relieve
uncomfortable symptoms (Giangregorio et al., 2008). Without open communication
between the provider and the patient and a mutual agreement and awareness that the
patient needs to take a medication, the likelihood for PNA is increased (Giangregorio et
al., 2008). These authors found that healthcare providers might contribute to the problem
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of non-adherence through poor communication and lack of making and discussing the
actual diagnosis with the patient.
Problem at system level. Calls to action by professionals in the field have
described and advocated for effective nurse practitioner-led models of care to improve
the care and treatment of osteoporosis and prevention of related hip fractures (Eiseman et
al., 2012; Marsh et al., 2011). Addition of the electronic medical record (EMR) and
information technology tools are solutions to meet focused goals and more efficiently and
effectively remedy this problem (Marsh et al., 2011). Marsh et al. (2011) used criteria
composed of 13 parameters, called the best practice framework and global campaign,
which outlined the qualities a successful fracture liaison service (FLS) program must
possess. According to the Centers for Disease Control (CDC; Crum, 2012), it is essential
that disease management programs adopt more information technology decision support
capabilities. These programs need to incorporate effective systems-based, preventive
healthcare strategies that will improve the quality and quantity of care needed to meet the
demands of a growing population.
Healthcare delivery systems of the near future will need to expand their capacity
to care for the growing needs of a diverse, chronically ill, and aging population (Crum,
2012). These systems will need to consider the needs of the patient as a member of the
healthcare team. If the patient is not a member of the team, he/she cannot be involved in
understanding the importance of taking the needed medications (Giangregorio et al.,
2008). The patient’s desire to cooperate is essential if program goals are to be met.
The computer can assist by bringing together the responsibility of the patient,
provider, and the system in the role of improving PNA because it can be used as a tool
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that can help with improving compliance through early identification of patients with
PNA and assisting the NP provider to contact the patient to intervene. Early
identification and access to pharmacy information can help the NP coordinate the care of
difficult patients. Management of PNA by hand is nearly impossible to achieve in a
paper-based system (Che, Ettinger, Johnston, Pressman, & Liang, 2005; Cheetham et al.,
2013; Kates, O’Malley, Friedman, & Mendelson, 2012). Improving access to
communication with the prescriber and pharmacy has lowered the rate of non-adherence
to medications (Kates et al., 2012). The computer is the key to accomplishing this.
Without a system in place, access to information and communication is less likely to be
effective.
Other barriers to implementing new practice tools or evidenced-based guidelines
also need to be addressed. Primary non-adherence is a major barrier in improving
outcomes of patients at risk for or diagnosed with osteoporosis (Silverman et al., 2011).
Methods to address this barrier need to include individual interventions targeting the
individual patients as well as changes in provider behavior, healthcare models, and
systems. Strategies to address PNA should focus on the use of information technology
tools and electronic medical records to measure the effectiveness of these strategies.
These strategies can assist the provider in easily accessing guidelines and patient and
pharmacy information (Che et al., 2005; Cheetham et al., 2013).
National Statistics
Worldwide, osteoporosis causes more than 8.9 million fractures annually,
resulting in an osteoporotic fracture every three seconds (NOF, 2013b). In spite of the
fact that hip fractures are preventable in patients with osteoporosis and acceptable
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treatment and prevention guidelines have been established, medical costs from fractures
continue to rise. Experts in the field agree that total medical costs from fractures will rise
by almost 50% to $25.3 billion in 2025 (Burge et al., 2007). Osteoporosis continues to be
under diagnosed and under treated. Only one-third of American women and fewer men
with osteoporosis ever receive treatment (Agency for Healthcare Research and Quality
[AHRQ], 2014; Eiseman et al., 2012; Gallagher, Grelig, & Comite, 2002; Marsh et al.,
2011; Solomon, Finkelstein, Katz, Mogun, & Avorn, 2003; Solomon, Patrick, Schousboe,
& Losina, 2014). Patient adherence is very important if goals of fracture reduction are to
be met. Brown and Busell (2011) stated that the number of patients who are nonadherent in taking their medications overall may be as high as 50%, which outlines a very
clinically significant problem. One out of every two women and one in four men over 50
will have an osteoporosis-related fracture in their lifetime (National Institutes of Health
Osteoporosis and Related Bone Diseases-National Resource Center [NIH], 2005).
According to the National Institutes of Health (2005), osteoporosis and related bone
diseases are responsible for more than two million fractures annually. As a result, the
National Bone Health Alliance (NBHA; 2013) has launched a campaign to increase
fracture awareness to the public (NOF, 2013b; NBHA, 2013). Hip fractures are the most
devastating of all fractures; 25% of those who suffer from a hip fracture will die within
one year. Additionally, hip fractures are associated with a 2.5 fold increased risk of
future fractures (NBHA, 2013; NIH, 2005).
Cooperation and proactive behavior amongst medical professionals is essential in
decreasing osteoporosis and subsequent hip fractures. Despite the recommendations and
support for osteoporosis disease management programs by the Centers for Disease
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Control (2010), National Osteoporosis Foundation (2013a), and Agency for Health
Research and Quality (2014), osteoporosis screening and treatment rates remain low
worldwide. Gallagher et al. (2002) found that only 12–34% of women at high risk for
fracture in a managed care network were screened for osteoporosis. Jachna and ForbesThompson (2005) cited that less than 50% of 1,200 adults aged 60 years or older
surveyed in the northeastern United States reported that their doctor even recommended
osteoporosis screening.
Developing methods for prevention and treatment of osteoporosis are critical to
ensuring better detection and treatment of this disease before major complications occur.
Heaney (2003) found there was inadequate participation of doctors in the proper
screening, prevention, and treatment of patients with fractures. Patients were not
receiving a DXA scan or treatment post fracture. Patients did not take their medications
if they were not told they had osteoporosis and did not understand the risks of not taking
their medications (Giangregorio et al., 2008). The American Society of Bone and
Mineral Research has recommended the implementation of more fracture liaison service
(FLS) programs to remedy this problem of patients not taking their medications (Eisman
et al., 2012; Reynolds et al., 2013). Despite the endorsement of many professional
organizations for FLS-type programs, treatment rates remain low. Lack of adherence to
treatment is further compounded by the problem of PNA. Even those patients who have
been prescribed treatment are non- adherent in obtaining or taking their medications
(Reynolds et al., 2013).
Solomon et al. (2003) reported that roughly four out of five patients in one hospital
system did not fill a prescription for an osteoporosis medication within six months after their
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incident fracture. The problem of PNA is a significant barrier. Thus, Reynolds et al.’s
(2013) research was the cornerstone and benchmark for this project, which calls for the
development and implementation of a tool to decrease the incidence of PNA.
Financial Impact
According to the 2004 U.S. Surgeon General's Report on Bone Health (U.S.
Department of Health and Human Services) and the National Osteoporosis Foundation
(2013b), osteoporosis is a major public health threat in the United States and has an
estimated cost of $18 billion each year (Burge et al., 2007). The cost of the Medicare
program alone is projected to increase 50% from 2012 to the year 2020 (Eisman et al.,
2012). This impacts the capacity of Medicare in financially supporting treatment in lieu
of dwindling resources. Based on available evidence, Medicare spending on preventable
hip fractures has sparked a concern to provide better, more cost-effective care (Eisman et
al., 2012; Marsh et al., 2011; National Committee for Quality Assurance [NCQA], 2010).
The majority of the costs of healthcare will be focused on providing services for older
adults who are at risk of fractures (Mitchell, 2011; NOF, 2013b). Approximately 20% of
patients who suffer a fracture due to osteoporosis will experience a repeat fracture in the
next five years (Solomon et al., 2014). They represent the highest risk group who would
benefit from treatment and lead to cost savings. Furthermore, Solomon et al. (2014)
calculated a cost analysis for treating fractures versus preventing fractures with the use of
an FLS program. They found that the FLS program reduced fractures and calculated that
significant projected reduced costs would ensue mainly due to early and effective
bisphosphonate treatment initiation. They stated that approximately 2.5 million
osteoporotic fractures occur each year and estimated that if all the post-fracture patients
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were cared for appropriately, the cost savings might equal as much as $16.7 million. The
savings would come largely from patients taking their medications (Newman, Ayoub,
Starkey, Diehl, & Wood, 2003; Solomon et al., 2014). According to recent data, the
generic medication, Alendronate, costs $250 per year while the cost of treating one hip
fracture is estimated to be $30,000 (CDC, 2010). This is a reduction from the previously
reported cost by the Geissinger study (Newman et al., 2003), which showed the cost of
hip fracture treatment was five times greater than the cost today for an oral
bisphosphonate. With the availability of generic Alendronate in 2008, the cost was
significantly reduced from previously brand named medication prices. By comparing the
two costs, the savings are evident and worth implementing (Solomon et al., 2014). The
steadily increasing cost of care and the work lost by those affected with osteoporosis and
fracture add billions more to this figure. With an aging population, the number of hip
fractures and related cost expenditures is expected to triple by 2040. The costliness of
osteoporosis and other related complications further highlight the need for
implementation of disease management programs (Burge et al., 2007).
Theoretical Framework
In applying a structured theory to practice, it is important to fully understand and
integrate applicable concepts, which come from life or clinical experiences (Chinn &
Kramer, 2010). According to Solomon et al. (2003), evidence alone is not a motivator in
changing provider practice or patient behaviors. Patient compliance and cooperation with
treatments are essential components to the success of any disease management program
(Solomon et al., 2003). To overcome the barriers to change, a comprehensive model that
incorporates theory and practice is needed. Information technology tools that focus on
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improving compliance with medications have the potential to facilitate improvements in
PNA and close care gaps (Kastner & Straus, 2009). According to the literature, the PNA
care gap is not currently being addressed. A care gap is defined as a treatment or action
that is not being appropriately applied.
Theoretical principles can be used to guide and improve the quality of practice.
One theory that could accomplish this is the theory of planned behavior (TPB; Ajzen,
1991). Theory of planned behavior deals with the link between beliefs and behavior.
The theory of planned behavior has been applied to studies that deal with attitudes,
behavioral intentions, and behaviors in different professions such as advertising, public
relations, and healthcare (Ajzen, 1991). According to Ajzen (1991), attitudes lead to
behavioral intentions that then lead to carrying out a behavior. A person must have the
intention to act upon it before it becomes a behavior. The TPB was created to predict
health behavior at particular points in time, to discover the variables that determine health
behavior, and to assess their ability to predict it. The theory adds to the concept of
behavioral change and control, which began from self-efficacy theory (SET). Selfefficacy was proposed by Bandura in 1977 and has a foundation in social cognitive
theory. The theory of planned behavior states that attitudes toward behavior, subjective
norms, and perceived behavioral control, together, shape an individual's behavioral
intentions and behaviors.
Theory of planned behavior provides the basis for understanding patient behavior
change related to medication adherence. According to TPB, patients’ attitudes and
control beliefs (self-efficacy) determine their action regarding adherence (Ajzen, 1991).
Interventions can be initiated that address patients’ attitudes, control beliefs, and
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perceived control, leading to changes in intention and behavior (Morisky, 2008). For
example, when the NP calls that patient who has not picked up their medication, it is
believed the telephone call and the NP acting as change agent will help the patient to
develop a new intention and then a behavioral change will occur. The way TPB affects
patient behavior is through the NP acting as change agent implementing the concepts of
TBP. The NP has a strong belief in TPB and relays this positive belief in TPB to the
patient during the telephone call. The patient is made aware of what is expected of
him/her by the healthcare provider and the patient gains knowledge of the importance of
taking the medication. The patient wants to do what is right—subjective norms, what is
expected of them by others—social norms, and will act within their physical ability to
make the change happen—perceived behavioral control.
Through TPB, the patient shall act of his/her free will, change the behavior, and
pick up the medication from the pharmacy. The laws of social norms, perceived
behavioral norms, and subjective norms (Ajzen, 1991) will be evidenced by the patient
changing his/her behavior. The patient will also have a change to verbalize that it was
the call that influenced his/her behavior due to the telephone outreach call. Theory of
planned behavior uses various beliefs that influence the perceived behavioral control of
the patient (subjective and social norms). In this project, a protocol for behavior change
was based on normative beliefs of the system and subjective norms (beliefs supporting
adherence of those interacting with patients). The system provided strong support for
behavior change through its ability to record, collect, and report data related to
medication adherence. Subjective norms were reflected through activities of the NP
coordinator who acted as the change agent and implemented the protocol supporting the

15
change. The protocol focused on interventions based on normative beliefs of the system
and subjective norms of the NP coordinator and other staff. The effect of the protocol on
the patient’s control beliefs, perceived control, and ultimately his/her behavior could then
be measured. The perceived behavioral control and control beliefs of the patient were
prerequisites to adopting adherent behaviors related to taking the medication. Utilizing a
protocol that incorporated the concepts from TPB and addressed both perceived control
and the patient’s self-efficacy was necessary for behavior change to occur.
According to Fawcett (2005), outcomes can be predicted and measured by using
an empirical referent. An empirical referent is defined as a concrete and specific
instrument, experiment, or procedure used to measure a concept. In this case, the
empirical referent was the Knowledge Builder Tool (KBT) computer system. The NP
used the KBT to measure the concept of PNA through a telephone outreach program.
According to Ajzen (1991), behavioral beliefs can determine the likelihood of how
successful one can be in changing a behavior in order to facilitate adherence of a
particular behavior. The stronger the belief that the NP would be effective in changing
patients’ behavior to pick up their medication from the pharmacy, the greater the
perceived probability that the new behavior produced a given, desired outcome. The
degree of belief about behavior change is directly connected to the favorable or
unfavorable outcome, also known as belief strength. One must have the motivation to
comply with the desired change (Ajzen, 1991). In this case, the change would be in the
staff’s belief that when the program was applied to their patients, it would result in the
desired effect of change in patient behavior to lower PNA. Prior to this study, there was
a baseline of 29.5% of patients who did not pick up their medications. This prior
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behavior had no influence on the NP until the tool was applied to make change. The TPB
has been used successfully to predict and explain a wide range of health behaviors and
intentions including smoking, drinking, health services utilization, breastfeeding, and
substance use.
The TPB states that behavioral achievement depends on both motivation
(intention) and ability (behavioral control). It is distinguished by three types of beliefs:
behavioral, normative, and control. The TPB is comprised of six concepts broken down
into three main areas; together, they represent a person's actual control over his/her own
behavior.
The first of the six concepts is called attitudes--the degree to which a person has a
favorable or unfavorable evaluation of the behavior of interest. The second is called
behavioral intention--the motivational factors that influence a given behavior. Where
there is strong intention to perform the behavior, the more likely the behavior will be
performed. The third concept is subjective norms--the belief about whether most people
approve or disapprove of the behavior. Subjective norms relate to a person's beliefs
about whether peers and people around them of importance think he or she should engage
in the given behavior. Subjective norms were very important to this project because the
NP knew her actions were being observed so she would do her best to act in a way she
believed was expected of her by her superiors. Next are social norms--the customary
codes of behavior in a group; these might only apply to what the NP believed she should
be doing in her scope of practice or what she believed should be applied to her tasks in
order to assist the patient to change his/her behavior and pick up the medication. Next is
perceived power--the perceived presence of factors that might facilitate or hinder
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performance of a behavior. The NP must work within a framework and has to believe the
time frame given, the environment, and the nature of the workload are reasonable.
Perceived power contributes to a person's perceived behavioral control over each of those
factors. The NP must believe she has some power over the situation in order to believe
her action will make a difference. The last action is perceived behavioral control--a
person's perception of the ease or difficulty of performing the behavior of interest.
Perceived behavioral control is related to perceived power over one’s environment. In
this project, perceived behavioral control applied to the specific telephone protocol,
which resulted in the patient exhibiting behavioral control to change his/her behavior and
pick up his/her medication when previously, prior to the intervention, he/she did not have
this intention.
Constructs of TBP and its application to this project were reduced to three main
influences that were the focus of this project: behavioral beliefs, normative beliefs, and
control beliefs. Behavioral beliefs are beliefs that the actions of the person would result
in desired change. Normative beliefs are when the person knows he/she is being watched
and so will want to perform in an acceptable way. Control beliefs involve the person’s
beliefs that he/she has some control over the environment and some control over the
ability to make change. These concepts of the NP’s beliefs in the context of the three
influences of TPB were especially important for this project.
The method used to evaluate the program was called the CDC framework for
program evaluation. The CDC (1999) framework for program evaluation is a systematic
approach to ensuring that questions worth significance of the program were addressed; it
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worked to engage stakeholders, described the program, evaluated the design, gathered
credible evidence, justified conclusions, and shared lessons learned.
In summary, the TPB process flow began with behavioral beliefs, turned into
normative beliefs, a development of an attitude toward the belief itself, and the person’s
perceived control that led to the formation of a behavior intention and ultimately the
action itself. The person developed his/her own free intention to perform the change
(Ajzen, 1991). It was very important that these three concepts be tied together and flow
in a systematic way in order for them to be effective in changing beliefs, behaviors, and
outcomes (Ajzen, 1991).
Literature Review
Osteoporosis and subsequent fracture affect millions of people in America and
worldwide. Many people who sustain a hip fracture never regain their previous level of
functioning (Burge et al., 2007; Eisman et al., 2012; Marsh et al., 2011). Although there
is unanimous agreement from all major osteoporosis societies around the world that
fragility fracture is preventable, efforts to date have not resulted in lowering the hip
fracture rate. Experts in the literature agreed that a fracture liaison service (FLS)
program is the most effective approach to fracture prevention. However, no one to date
has been able to address all of the barriers to effectively closing persistent care gaps that
result in increased fracture risk and subsequent fracture (Eisman et al., 2012; Marsh et al.,
2011; Siris et al., 2006). The most important element of the FLS program for fracture
prevention is the early identification and treatment of patients at risk for a hip fracture
with a bisphophonate (Dell, 2011; Siris et al., 2006). Until recently, the problem of
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primary non-adherence has not been known. There is little research to support the
findings or solutions to PNA (Reynolds et al., 2013).
Bisphosphonates are the medications of choice for the treatment of osteoporosis
(Eisman et al., 2012; Marsh et al., 2011; Siris, Boonen, Mitchell, Bilezikian, &
Silverman, 2012; Siris et al., 2006). When osteoporosis is diagnosed by dual energy
absorptiometry (DXA) scan or by fragility fracture, the patient will often suffer a
subsequent fracture if not treated. Fifty percent of the time without adequate treatment
after a fracture, the patient will go on to suffer a second fracture (AHRQ, 2014; Eisman et
al., 2012; Marsh et al., 2011; NOF, 2013a).
The literature stated that it is necessary to use the electronic medical record
(EMR) and incorporate information technology (IT) such as the Knowledge Builder Tool
(KBT) to further investigate non-adherence to bisphosphonate medication and the causes
of it (Dell, 2011). Patients who do not take their medication cannot receive the fracture
risk reduction a bisphosphonate provides. A bisphosphonate has been shown to be the
best way to reduce fracture risk by 50% (Ensrud et al., 1997). Studies (Burge et al., 2007;
Eisman et al., 2012; Ensrud et al., 1997; Marsh et al., 2011; Sirris et al., 2006; Solomon
et al., 2014) supported the early initiation of bisphosphonate treatment in lowering the hip
fracture rate and lowering the huge economic burden of osteoporotic fractures when the
problem is not addressed properly and secondary fractures result. Subsequent fracture
incidences cause increased care costs due to the severe morbidity and mortality
associated with fracture. Without control, this problem and associated costs are predicted
to increase dramatically in the future (Burge et al., 2007).
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Research studies such as one conducted by Marsh and colleagues (2011) and
articles written by Eisman et al. (2012); Dell, Greene, Schelkun, and Williams (2008);
Dell, Greene, Anderson, and Williams (2009); and Dell (2011) all added to the body of
knowledge and provided evidence that has helped to further develop fracture liaison
service (FLS) programs, care pathways, risk assessment models, and calculators. These
authors indicated the importance of early identification and treatment using a dedicated
NP coordinator and a systems-based approach that includes initiation with a
bisphosphonate medication as critical to lowering the hip fracture rate.
This evidence was the foundation upon which this capstone project was built.
Morbidity and mortality rates related to hip fracture are high--up to 25% of patients die
within the first year following a hip fracture. Less than half of those who survive the hip
fracture regain their previous level of function (Center, Bliuc, Nguyen, & Eisman, 2007).
Silverman et al. (2011) and Silverman and Gold (2008) showed that PNA is a major
problem, resulting in continued hip fracture regardless of other factors. Implementation
of an FLS program and the process of continuous quality improvement could identify and
set new goals to meet fracture reduction goals. The FLS program uses continuous quality
improvement and information technology tools to monitor progress and identify new
problems that need to be addressed (AHRQ, 2014; Dell, 2011); progress is measured and
monitored by the program NP coordinator through documentation of performance goals
and outcomes. This information is shared between medical centers. Friendly
competition helps each medical center meet their bench mark and shows how each
program is progressing (Dell et al. (2009). The program with a systems approach allows
for continuous feedback that keeps the program aware of which goals are being met,
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which measures are not being met, and what might be needed to address the problem or
make changes (Dell, 2011; Eisman et al., 2012; Marsh et al., 2011; Reynolds et al.,
2013). Currently, PNA is a major barrier compounding the problem of missed
opportunities for fracture reduction (Reynolds et al., 2013; Silverman & Gold, 2008).
The only way to meet fracture reduction goals and see cost savings is through the
implementation of an FLS program that uses a dedicated program coordinator such as an
NP (Eiseman et al., 2012; Reynolds et al., 2013; Silverman & Gold, 2008).
Reynolds et al. (2013) investigated the Kaiser Permanente Healthy Bones
Program (KPHBP) Southern California pharmacy database and reviewed records of
8,454 women who were prescribed a bisphosphonate treatment for post fracture care.
Results revealed that 29.5% of the women who had been prescribed medication did not
pick up the medication for 60 days. These women fulfilled the criteria for being nonadherent based on the authors’ definition of PNA. Reynolds et al.’s study was used as a
benchmark because it was the only study to date that identified and quantified the
incidence rate of PNA in bisphosphonate use.
Another prospective observational study (Dell, 2011) evaluated the changes of
osteoporosis disease management in the Kaiser Southern California Health-Maintenance
Organization (HMO) for the years 2002 to 2006 inclusively. The Kaiser Permanente
electronic medical record (EMR) called HealthConnect was used to gather data on antiosteoporotic medication prescriptions written, dual x-ray absorptiometry scans (DXA),
demographic information, and information related to hip and other fragility fractures in
more than 620,000 patients. The results revealed that through a team approach using a
NP champion to provide leadership in a disease management program, the fracture rate
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was reduced by greater than 40%, saving millions of dollars and preventing hip fracture
(Dell & Greene, 2010; Dell et al., 2008; Greene & Dell, 2010; Newman et al., 2003).
Burge et al. (2007) discussed the impact of the lack of fracture management on
the skyrocketing costs of fracture care in the United States and world-wide.
Comparatively, cost savings were demonstrated by using information obtained from
fracture liaison service (FLS) in the United Kingdom (National Health Service and The
National Health and Care and Excellence) and the National Institute for Health (NIH) in
the United States (AHRQ, 2002; Compston, 2010; Mitchell, 2013). In the United
Kingdom, The National Health and Care and Excellence (NICE) has demonstrated that
through the example of the fracture pyramid, FLS type programs could use the cost
savings gained to pay for future program costs associated with the successful evolution
and sustainment of the program (Mitchell, 2013). A pyramid gives a visual depiction of
how it is possible to use cost savings from the program to pay for other interventions and
further lower cost (see Figure 1); costs could be distributed to address the top of the
pyramid and work down to use money saved in highest risk groups to address other
patients at risk for fragility fracture (Mitchell, 2013). Hip fractures are the most costly of
all fractures. The pyramid was one example of the foundation upon which this capstone
project was based. The reason for the development of the telephone outreach program is
to lower the rate of PNA; a dedicated NP coordinator was able to implement early
identification of patients at risk for a hip fracture and then initiated and monitored the
treatment of patients with a bisphosphonate therapy. This action is the most effective
method in lowering the hip fracture rate. Reynolds et al. (2013) identified the rate of
PNA in this bisphosphonate population; however, no protocols were developed to address
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how this rate could be lowered. Improving overall adherence has been noted by several
researchers (Cook, 2008; Cook, Emiliozzi, & McCabe, 2007; Giangregorio et al., 2008);
all suggested that the incorporation of a telephone outreach protocol was effective in
improving patient adherence to medications.

Figure 1. The fracture pyramid (Marsh et al., 2011).

Kanis, Johnell, Oden, Johansson, and McCloskey (2008) and the World Health
Organization developed a risk calculator called FRAX, which assists the provider in
various countries around the world in making cost-effective treatment decisions based on
a series of questions that reveal the patient’s probability of fracture and whether or not
treatment is advised (Kanis et al., 2008). Both the online calculator (FRAX) and the
fracture reduction pyramid model diagram are examples of tools to help guide costeffective treatment methods that can be used to guide practice (Kanis et al., 2008;
Mitchell, 2013). However, the patient must first pick the medication up from the
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pharmacy in order for any cost-effective models to work as intended (Reynolds et al.,
2013).
Nayak, Roberts, and Greenspan (2011) also made comparisons in their study to
the improvements in the cost of treating patients with a bisphosphonate compared to not
preventing and treating a costly hip fracture. They found that oral bisphosphonate
treatment was estimated to have an adherence rate of 50% and a patient transient habit of
five year on and off treatment patterns with no official program in place. Nayak et al.
(2011) and Sale et al. (2011) found that of the strategies for postmenopausal osteoporosis,
screening and compliance to treatment were most cost-effective when initiated by age 55
because the risk of fracture increases with the age of the patient. Adherence to the
medication prescribed in this age group is improved especially if the provider discusses
the diagnosis and importance of the treatment with the patient (Giangregorio et al.,
2008).
Another comprehensive review (Dell & Greene, 2010) of osteoporosis fragility
fracture prevention focused on cost-effective strategies to decrease fracture risk. This
study focused on how to cost-effectively identify, risk stratify, treat, and then track
patients at risk for osteoporosis and fragility fractures in the KP Healthy Bones Program
(Greene & Dell, 2010). The Southern California Kaiser Permanente Healthy Bones
Program (KPHBP) showed that with the use of a fracture liaison service (FLS) program
and treatment with a bisphosphonate, four fragility fractures were prevented in every 100
patients who were treated (Dell et al., 2008). This information is useful in predicting cost
savings for a program when it is applied to a large population of patients. Bogoch et al.
(2006) found similar cost savings results in their fracture treatment program by using
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similar techniques of FLS intervention. Early identification and treatment resulted in
reduction in the fracture rate--out of every 100 patients treated, six fractures were
prevented in their large patient population.
Dell (2011) confirmed cost savings data gained from using an FLS systematic
approach to fracture prevention and early bisphosphonate treatment initiation. Based on
four to six hip fractures for every 100 patients treated with bisphosphonates, the cost of
treatment decreased due to the lower cost of generic forms of bisphosphonate
medications. Solomon and colleagues (2014) further synthesized this cost savings
information and determined that the cost of bisphosphonate medication was currently
$250 per year compared to $507 per year 10 years ago.
Original examples of cost savings were seen with the Geissinger Health System
study (Newman et al., 2003) of their osteoporosis disease management program. Based
on results of their study, recommendations were made to increase diagnosis and treatment
of osteoporosis in a more systematic and organized approach than was being done
typically in other health centers. The Geissinger Health System was one of the first
chronic disease management programs that used clinical practice guidelines in such an
effective manner to address osteoporosis disease management and to prevent fractures.
From 1996 (inception of their program) until 2003, the Geissinger Health System
performed more than 75,000 DXAs and increased their utilization of bisphosphonates.
Cost savings results were evidenced by a five-year analysis that showed a decrease in the
hip fracture rate of approximately 40% (Newman et al., 2003). Although further
projections of cost savings by Solomon et al. (2014) included the cost of office visits,
treating side effects, and the cost of buying the medication, the Geissinger Health Study
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was purely an estimation of the cost of buying the medication. Professional societies
such as the American Society for Bone and Mineral Research have supported initiatives
to employ best practice standards of care such as using a fracture liaison service (FLS)
coordinator and implementing early treatment with a bisphosphonate (Dell et al., 2008;
Eisman et al., 2012; Greene & Dell, 2010).
Other components in providing cost effective care to specifically close the PNA
care gap include the addition of an EMR and information technology (IT) tools (Che et
al., 2005; Cheetham et al., 2013). The IT and EMR tools have been shown to optimize
both care provided and outcomes achieved (Che et al., 2005; Cheetham et al., 2013). The
EMR is an effective tool in lowering hip fracture rates cost effectively through improved
record keeping and the facilitation of communication techniques such as telephone
outreach (Che et al., 2005; Cheetham et al., 2013). The KBT computer enhances
communication by providing medical record information in real time for providers to
access. The provider has the information readily available to use during phone calls and
communications with the patient and with other providers as necessary. The computer
uses alerts and reminders that can communicate to providers the tasks to be done. The
computer is able to automate communications with the patient such as letters that remind
patients to make follow up appointments. Without the computer, the provider would
have to rely on the patient to provide up-to-date historical information or to wait for
paper charts to arrive, which might not contain current information. This lack of readily
available information makes the provider appear unfamiliar with the patient’s case or
his/her needs (Che et al., 2005; Cheetham et al., 2013). Computer information
contributes to the overall body of knowledge by showing that fracture reduction goals can
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be more easily met by enhancing awareness about chart information, improving
communication, and tracking of results that cannot be done in a paper-based system (Che
et al., 2005; Cheetham et al., 2013). It is important for the provider to be directly familiar
with the patient’s case, lab results, and diagnosis in order to build rapport and trust with
the patient. Lack of current knowledge by the provider during communication with the
patient might affect the patient–trust relationship (Che et al., 2005).
Causes of Primary Non-Adherence
at the Patient Level
Factors at the patient level need to be addressed in determining the cause of PNA
in the literature. It is important to look at the baseline reasons in the literature of why
patients have self-reported they did not pick up their medications. Greenwald et al.
(2002) used a patient self-reported survey (n = 144) to investigate the reasons patients
had not picked up their bisphosphonate medications in 30 days. Similar to Reynolds et
al. (2013), Greenwald and colleagues found that after 30 days, 37.5% of the patients in
this study were shown to have PNA. Although their study did not exactly match 60 days,
the reasons patients did not pick their medications after 30 or 60 days did not differ
(Reynolds et al., 2013). Reynolds et al. looked at increments of time at two weeks, 30
days, 45 days, and 60 days. The main reasons for non-adherence in the Greenwald et al.
(2002) study given by patients were a deficiency in the communication about the
medication, the lack of understanding regarding the need for the medication, and many
simply forgot to pick it up from the pharmacy. Another study by Waalen, Bruning,
Peters, and Blau (2009) showed that 28.5% of women over 60 years of age (n = 102) did
not pick up their bisphosphonate medication after a new diagnosis of osteoporosis in one
year.
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McHorney et al. (2008) and Sale, Beaton, Sujic, and Bogoch (2010) both reported
common reasons patients gave for not picking up their medications: osteoporosis health
concerns, drug costs, dosing frequency convenience, and potential for experiencing side
effects. Multivariate analyses conducted by Sale et al. on 1,092 (33%) women showed
that patients commonly were more adherent if they believed the drug would help them or
if it would relieve uncomfortable symptoms. Based on these studies, non-adherence was
directly connected to patient beliefs; they must believe they need the medication in order
to relieve symptoms, to improve their outcomes, and if the risk of side effects are
minimal. Moreover, Sale et al. stated that reasons for non-adherence were not consistent
and might even evolve or change with time. Transient patient beliefs make it especially
difficult to understand, measure, or to monitor compliance. Better systems using
information technology could provide the methods by which behaviors could be
monitored (Sale et al., 2011).
Sale et al. (2011) studied the specific reasons for non-adherence through selfreports of patients. They concluded that self- reported questionnaires might not be
reliable or objective sources of data. When patients reported that they forgot to pick up
their medication, they did not want to reveal their real reasons for fear of appearing
uncooperative (Sale et al., 2011). Sale et al. further concluded that patients might be
more truthful with their reporting if there was more open communication between
prescribers, which would make patients feel more comfortable in disclosing all truthful
reasons even if against the advice of the medical prescriber. Through more open
dialogue, patients might feel less inhibited or judged by healthcare providers and might
feel more comfortable in being frank with their responses, which might be based on fear
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of a medication side effect or lack of education. Both the patients and healthcare team
must work harder to improve health literacy problems. More accurate patient responses
occur if patients are in a more relaxed, non-judgmental environment.
Reynolds et al. (2013) and Cheetham et al. (2013) showed that undesirable side
effects of medications experienced by the patients were found to be more closely
connected with secondary and not primary non-adherence because those patients with
secondary non-adherence (SNA) had already previously picked up and started the
medication and then suffered an undesirable side effect. Secondary non-adherence
occurs when patients self-stop the medication and do not refill it again (Cheetham et al.,
2013; Reynolds et al., 2013).
McHorney and Spain (2011) conducted a study in which patients self-reported
reasons why they did not fill their new prescription medications. The results showed a
direct association between reported reasons for non-fulfillment (PNA) and nonpersistence (SNA) as compared to their particular chronic disease, which might be
different and even change at times. McHorney and Spain further indicated that patients
were motivated by fear of having a serious health consequence for not taking a needed
medication. The patient must believe it is important for them to take their medication
(McHorney & Spain, 2011).
According to Gadkari and McHorney (2010), one in three patients never picks up
their medications from the pharmacy. They found the way patients perceived their
disease condition or their perceived need for the medication, fear of side effects, and
whether or not the medication would relieve an uncomfortable symptom played a large
role in whether or not they took the medication. In their meta-analysis, 79 studies
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reported pure nonfulfillment rates--59 at the patient level, 20 at the prescription level, and
six in combination with non-persistence. The non-adherence rates ranged from 0.5% to
57.1%. Three primary reasons for non-adherence were identified: (a) perceived concerns
about medications, (b) lack of perceived need for medications, and (c) medication
affordability issues. In this meta-analysis review, patient reasons for not filling their
medications were consistently the same.
In a meta-analysis of 127 articles, Silverman et al. (2011) investigated patient
reasons for non-adherence to medications used to treat osteoporosis, cardiovascular
disease, and other chronic disease medications. They found that suboptimal health
literacy and lack of patient involvement in his/her treatment decisions by providers were
reasons patients did not take their medication as prescribed. Other findings included
communication barriers about the medications and disbelief by the patients that they
needed the medication. Ineffective communication of information about adverse effects
and too many different physicians caring for multiple patient conditions were also causes
for non- adherence (Silverman et al., 2011). Since the prescriptions in this study were
written largely for bisphosphonates, the findings were generalizable to osteoporosis as
well as other chronic diseases (Silverman et al., 2011
Poor patient health literacy and lack of patient involvement in decisions related to
treatment were found to be amongst the main contributing factors to PNA in a study by
Elliott and Marriott (2009). This study investigated why patients did not initially pick up
their medications from the pharmacy. In addition to health literacy problems, older
people are commonly prescribed complex multi-drug regimens while also experiencing
declines in cognitive and physical abilities required for medication management. This
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could lead to increased risk of medication errors and need for assistance. This study
reviewed published instruments designed to assess patients' capacity to self-administer
medications and to gain useful information. This information might justify the need for a
tool to assist the provider in identifying patients who are not picking up or taking their
medications and intervene through communicating with the patient to prompt them to
take their medications as prescribed (Elliott & Marriott, 2009).
In summary, the patient has a responsibility to make sure he/she has his/her
questions answered by the provider. The patient must make sure he/she is
communicating with the provider and letting the provider know if he/she does not
understand the instructions given. The patient’s responsibility is to take a more active
role and become an active participant in his/her own care. Patients need to be
empowered to include themselves in a shared decision-making process.
Causes of Primary Non-Adherence
at the Provider level
Providers must understand the importance of patient involvement in his/her own
care. Patient goals must include the patient—he/she must be included as part of the team
in a shared decision-making process that will help him/her understand the importance of
participating in his/her own care (McCormack & Loewen, 2007). In a study by
Giangregorio et al. (2008), patient belief in the perceived importance of the medication
and the connection to his/her fracture risk was found to be a very important predictor of
PNA. One hundred twenty-seven women in their 60s were interviewed about their
beliefs and the connection between their medication and their own fracture risk reduction.
The findings showed 82% of the women interviewed had a new prescription for a
bisphosphonate but no diagnosis of osteoporosis, had no conversation with the provider

32
about the importance of taking the medication, and did not believe there was a link
between osteoporosis and their own individual fracture risks. The women in this study
placed no increased importance on taking prescribed medications for osteoporosis if they
did not know they had osteoporosis and had no uncomfortable symptoms they wanted to
treat. The study concluded that the women did not believe they needed to take
medication because their doctor did not discuss this problem with them and they had no
symptoms. However, when an actual diagnosis of osteoporosis was made in a different
group of 56 women and compared to those patients without a diagnosis, the patients who
had an actual diagnosis of osteoporosis believed there was a link between osteoporosis
and their fracture risk. Overall, 17% of the women thought their fracture was related to
osteoporosis. Less than 50% of the women believed they personally had any risk of a
fracture (p < 0.001). This study concluded there is a need for better communication
between providers and patients and better ways to determine risk of PNA. If the
physician does not communicate the importance of the medication or does not note in the
medical record that this medication is indicated, then the mediation will usually not be
taken by the patient (Giangregorio et al., 2008).
Patient compliance is a key factor to the success of any disease management
program (Solomon et al., 2003). It is the provider’s responsibility to make sure patients
are included as a team member and practice shared decision-making to empower patients
to feel that their thoughts and feelings are important (McCormack & Loewen, 2007).
However, compliance and predictions of patient compliance are difficult to measure.
According to Sale et al. (2011), labelling patients or grouping them into categories such
as being adherent or non-adherent is not productive because it sets stereotypes and
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negative messages; the reasons for non-adherence often change with time and are not
consistent. Sale et al. (2011) showed that in a university teaching hospital fracture clinic
program, individuals aged 65 and older who had sustained a fragility fracture within five
years were at high risk or future fracture; once identified, they were enrolled in the study
and prescribed a bisphosphonate medication. More than half of the patients revealed that
the decision to take their osteoporosis medication was a difficult and usually not a
permanent one; this substantiated Sale et al.’s findings that a patient’s decision to take a
bisphosphonate is transient and changes over time. It is the provider’s responsibility to
understand this and to maintain consistent interventions designed to enhance
communication aimed at changing and maintaining patient beliefs and behaviors. One of
the reasons cited by half of the patients in the study was patients were unconvinced by
their health care provider that they needed to take the medication. Thus, providers need
to take a more active role in assuring their communications are actually effective; they
should not just assume without verifying that patients actually understand what is
communicated or taught to them. In addition, patients showed concern about side effects
of the medication. In the final analysis, many of the patients said their osteoporosis
medication-taking status might change at a later date and that they are not permanently
convinced they wanted to take the medication (Sale et al., 2011).
Brown and Bussell (2011) found the provider has a responsibility to assure that
the patient is included as a team member and is allowed to be in the shared decisionmaking process related to their care. Findings from this study showed that provider level
related causes of non-adherence including patient-provider communication barriers, lack
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of knowledge about potential side effects, and lack of health information technology
systems in place also contributed to PNA (Brown & Bussell, 2011).
To date, a traditional style of health education has centered on the disease process
and pathophysiology of disease. This type of education alone and not in coordination
with a FLS disease management type program has been shown to be ineffective in
changing patient behavior such as PNA (Solomon et al., 2003). Traditionally, the
physician model focuses on diseases and how they are treated. Solomon et al. (2014)
confirmed that if the patient knows more about their disease and is educated with the
same model of teaching the physician was taught, then the patient will become more
adherent to prescribed medical treatments. The education a patient receives must be
meaningful to the patient; the patient must see the perceived value to him/her before any
change in health related behavior can occur stemming from provider teachings (Solomon
et al., 2003). Solomon and colleagues (2003) explained that although education is
important and the provider must talk to patients and teach them, without the coordinated
efforts of a program such as an FLS program and a nurse practitioner (NP) coordinator to
act as the glue that holds patients and treatments together, education alone will fail to
impact patient outcomes. Additionally, Dell (2011) agreed that information technology
tools and the assistance of an NP-led patient education program without coordinated
efforts of NP clinic visits will not effectively impact hip fracture reduction (Greene &
Dell, 2010).
It is essential that NP coordinators close care gaps if there are to be successful
results in the effective coordination of meeting care goals (Greene & Dell, 2010;
Solomon et al., 2003, 2014). Solomon and colleagues (2003) showed that continued
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under-treatment of osteoporosis in patients persists; using education techniques alone
have been completely ineffective. Despite many attempts to improve patient knowledge
with patient education classes, the problem remains unchanged. Patients are motivated
by different factors; thus, any intervention to improve health literacy must be focused on
the individual and associated causes (Solomon et al., 2003). Providers have a
responsibility to implement techniques that focus on patient needs rather than using care
delivery that is convenient for the provider.
The literature clearly showed that the human interaction associated with follow up
by the NP and phone calls as part of a telephone outreach effort played a key role in
giving more customized care and enhanced communication as opposed to other studies
that used only patient questionnaire feedback in which patients claimed they simply
forgot to pick up their medication. It is the provider’s responsibility to make sure the
patient understands the information given during the visit and allows the patient to ask
questions. This communication component assists patients in deciding whether or not to
not take their medications. In summary, patient reasons for not picking up their
medications are individualized and transient. Often, patients who do not pick up their
mediations did not forget to pick it up but made conscious decisions not to pick up or
take their prescribed medication.
In their meta-analysis, Elliott and Marriott (2009) evaluated the development and
validation of instruments designed to assess patients' capacity to self-administer
medications. The authors showed that healthcare providers must persist with
communicating with patients who have not initiated their bisphosphonate prescription.
Their meta-analysis indicated that patients might benefit from knowing what to expect
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from taking the medication and to include benefits and the time it takes to work. The
study concluded it is the provider’s responsibility to improve the health literacy of the
patients as well as maintain their own health literacy.
In summary, providers must communicate with the patient the importance of
taking the medication, what to expect, the benefits of taking it over the long-term, and
any side effects. Multiple opportunities are available to use technology to boost patient
compliance rates and make it easier for patients to become more involved in their own
care (Elliott & Marriott, 2009). It is important that the provider include the patient in
their care and considered the patient as a team member in order to improve patient
outcomes (Elliott & Mariott, 2009).
Causes of Primary Non-Adherence
at the System Level
Improvements in health literacy and information technology could contribute to
better care and a decrease in the incidence of non-adherence (Dell, 2011). In this case,
the computer provides information to the NP in real time to assist with tracking patient
compliance and provides a protocol to be followed for telephone outreach. The computer
as part of the system can assist the provider in making a diagnosis of osteoporosis, which
has been shown to directly improve patient adherence in taking the medication as
prescribed (Giangrigorio et al., 2008). Dell (2011) added that the computer can assist in
this process by providing tools in the form of clinical practice guidelines, risk calculator
tools, and patient chart information such as diagnostic tests in real time. These tools
could assist the NP provider in making the diagnosis and determine whether or not
treatment is advised. The computer could enhance better communication by providing
tools and information that can decrease variation in practice and might add information to
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dispel myths so a stronger connection can be made between osteoporosis and fracture risk
by patients (Dell, 2011; Giangregorio et al., 2008).
Inclusion of an actual diagnosis on the chart and patient awareness of the
diagnosis of osteoporosis might improve this association. The provider could use the
electronic medical record (EMR) as a useful tool in improving health literacy for other
healthcare providers as well as patients to reduce the incidence of PNA (Che et al., 2005).
A clinical practice guideline (CPG) could guide practice and improve communication to
the patient when it is embedded into the EMR. Alerts and reminders would tell a
provider when a patient has not picked up their medication so they can be called and
communication can be initiated (Cheetham et al., 2013). The EMR could also be
programmed with a patient’s past behaviors--the best predictors of future behavior. The
computer system is an essential component to the tracking and documenting of patients in
order to monitor their compliance.
Bardwell et al. (2002) examined medication-taking health beliefs in patients and
analyzed how their beliefs affected their past history of compliance with taking
prescription medications. The data were analyzed using a predictive tool comparable to
one of the functions available as part of the Knowledge Builder Tool (KBT) in order to
determine if past non-adherent behavior could be used to predict future non-adherent
behavior. Results of this study demonstrated it was possible to predict non-adherent
behavior and predictive models might be helpful tools for providers to use when any new
prescription is written. This information could be helpful when revising the program to
further improve the rate of PNA once current goals are met. When the problem is
identified, then the prescriber can adequately intervene with additional communications
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to help dispel any myths or fears and attempt to change patient beliefs so they can
understand the importance of taking their medication (Bardwell et al., 2002).
Another factor that contributes to PNA at the system level is an inability of
providers to retrieve patient data and medical chart information so they can provide
patient care in real time (Dell, 2011; Greene & Dell, 2010; Siris et al., 2006). As noted in
the literature, this barrier at the system level might be resolved by the added ability of the
provider to track whether or not the patient has picked up a prescription medication once
written. Lack of electronic prescriptions and an overall lack of communication and
access to chart information directly affect the PNA rate (Che et al., 2005; Cheetham et
al., 2013). Simply put, a treatment cannot work if the patient does not take it and the
prescriber cannot track it.
Lack of integrated systems with pharmacy data and no existing FLS type program
in place designed to assist the provider minimize PNA have contributed to the ongoing
problem. This lack of a coordinated system has made it more difficult for healthcare
providers to monitor and measure compliance. Thus, a coordinated system in place
would assist in lowering the hip fracture rate and improve non adherence through the
coordinated efforts of a dedicated coordinator (Dell, 2011; Siris et al., 2006, 2012). Use
of FLS programs that use a nurse practitioner (NP) coordinator to take responsibility for
patient care and outcomes and maintain telephone outreach and computer systems are
helpful in decreasing the hip fracture rate (Cook, 2008; Siris et al., 2006). Simply put,
fractures negatively impact patient outcomes due to the lack of proper systems in place
and lack of medication treatment with a bisphosphonate (Akesson et al., 2013; Dell,
2011; Dell et al., 2008; Greene & Dell, 2010; Marsh et al., 2011; Siris et al., 2006). The
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NP is able to identify, risk stratify, diagnose, treat, and follow up with patients to meet
program goals. Bisphosphonate therapy is the best intervention to lower the risk of hip
fracture and prevent subsequent fractures (Akesson et al., 2013; Dell, 2011; Dell et al.,
2008; Ensrud et al., 1997; Greene & Dell, 2010; Siris et al., 2006).
Patient non adherence to medication treatment can have a kind of domino or
cascade effect--one event affects the other. If medications are prescribed after a fracture
occurs and the patient fails to acquire the medication and take it, then he/she does not
benefit from it and his/her individual fracture risk goes up (Brown & Bussell, 2011; Dell,
2011; Eisman et al., 2012; Marsh et al., 2011; Silverman & Gold., 2008; Silverman et al.,
2011; Siris et al., 2006). A coordinated program that considers patient, provider, and
system factors is necessary to reduce PNA and improve patient outcomes related to
fractures in patients with osteoporosis.
A coordinated program such as the Kaiser Permanente (KP) system could identify
patients with osteoporosis or who are at risk for hip fracture, systematically intervene,
and then monitor and follow up with each patient accordingly. With the system in place,
the NP could receive a list of patients who have not picked up their bisphosphonate
prescription from the pharmacy. The NP in this project would be the key component to
this coordinated effort. However, when there is no NP coordinator and no coordinated
system is in place, the computer alone cannot improve patient outcomes without the
organized effort of all program components (Solomon et al., 2003). Without the
computer system in place, the provider might not be aware the patient is not taking the
medication and thus not benefitting from the treatment (Brown & Bussell, 2011;
Cheetham et al., 2013; Marsh et al., 2011; Sale et al., 2011; Silverman & Gold., 2008;
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Silverman et al., 2011; Siris et al., 2006). The fracture liaison service (FLS) program and
theoretical framework would provide the structure and protocols.
Description of the Knowledge Builder
Tool and Improvements in Quality
The days of the paper chart are changing into a new era of the electronic medical
record (EMR). The EMR must be designed and organized to facilitate a process that is
useful and can be used as a tool to close care gaps and to improve patient outcomes while
maintaining quality at an affordable cost (Dell, 2011). The KBT takes the data from the
EMR and converts it into actionable knowledge that can be used by care managers to
close care gaps. Data are updated daily and the care manager can receive current
information about DXA, laboratory results, medication treatments, and demographic
information. The KBT updates the current state of the patient’s health condition and then
populates the information in the form of patient lists, creating a complexly interactive
disease registry. The KBT was developed to reduce the barriers associated with
implementing knowledge into practice with the intention of improving quality care (Dell,
2011). The Kaiser Permanente Knowledge Builder Tool (KBT) was developed by the
internal infrastructure of the Kaiser Permanente Information Technology Department in
coordination with the Healthy Bones Program; it is being implemented as a component of
their osteoporosis disease management program to assist the NP care manager in
managing problems in large populations and closing care gaps such as PNA. The KBT
was tested internally by over 50 Kaiser Permanente providers and was shown to be a
reliable and valid tool (Personal communications, Dr. Dell, physician champion of the
KPHBP, and Xuan Chen, senior data consultant, on December 12, 2013). During the
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year end KPHBP core meeting, the validity of this tool was demonstrated and confirmed
through an internal validation process (Dell, 2011).
The literature provided examples of how the EMR is a useful tool and enhances
the safety of prescribing and monitoring medication side effects (Cheetham et al., 20l3;
Halvorson, 2009; Institute of Medicine [IOM], 2006). It is important to the success of a
program to incorporate computer technology tools to close care gaps such as PNA. The
IOM (2006) publication To Err is Human calls for the use of integrated IT systems to
reduce the incidence and inefficiencies of the current medical system. These systems
could effectively manage chronic health care problems safely and effectively at the level
of the patient as well as the population. Halvorson (2009) described the Healthy Bones
Program (HBP) as an ideal example of how a chronic disease management program
should work. The HBP has made great contributions to healthcare delivery through early
identification of problems. This program helps overcome barriers to meeting quality
improvement goals. It is an example of a coordinated system that uses IT and NP care
coordination to reduce hip fractures. The HBP uses the EMR and tools such as the KBT
to provide the means through which adherence of patients with chronic health issues such
as osteoporosis can be monitored, managed, and tracked (Dell, 2011; Halvorson, 2009).
These systems facilitate management of side effects, improve safety and efficiency of
practice, and close care gaps. The KBT was developed internally as a part of the EMR
that is used to collect data and provide NPs with specific patient lists to address persisting
care gaps--in this case, PNA (Dell, 2011; Halvorson, 2009).
Katzen and colleagues (2011) also supported the future development and use of
the EMR and tools that could store and use clinical and administrative data. With an
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EMR, the data are typically stored in a central warehouse and can be accessed directly
and in real time (Katzen et al, 2011). Clinical decision support tools found in EMRs
aimed at improving compliance have made great contributions to the improvement of
primary non-adherence to medication (Kastner & Straus, 2009). Clinical decision
support tools such as the KBT within an FLS program could be used to close care gaps
and use the evidence to directly translate knowledge into practice. This practice
translation is evidenced by improvement in patient outcomes.
Kastner and Straus (2009) advocated clinical decision support and the application
of knowledge into practice by using a decision support tool and a knowledge to
application model of care to transform information to knowledge to practice. In Crossing
the Quality Chasm: A New Health System for the 21st Century, the Institute of Medicine
(IOM; 2010) described PNA as an example of a care gap. The IOM discussed the benefit
of using knowledge to close care gaps.
Limitations of the Literature
Over the past decade, much energy has been focused on FLS program model
development as a cost-effective team approach to reduce fracture risk through
coordinated program efforts. The American Society of Bone and Mineral Research
(ASBMR), National Osteoporosis Foundation (NOF), International Osteoporosis
Foundation (IOF), and others have recommended the implementation of coordinated FLS
type programs to prevent fracture and lower the hip fracture rate (Eisman et al., 2012;
Marsh et al., 2011). To date, a paucity of research is available related to addressing the
PNA problem (Eisman et al., 2012). Eisman et al. (2012) reported on recommendations
made by the ASBMR Task Force for the implementation of an FLS type service geared
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toward early identification and initiation of a bisphosphonate and the monitoring of
patients on medication treatment to lower the incidence of preventable fracture (Dell,
2011; Eisman et al., 2012; Marsh et al., 2011).
Although researchers gave recommendations for fracture prevention based on
current available knowledge and from their own work and programs, hip fracture remains
an ongoing problem. The ASBMR Task Force synthesized the literature and published a
position paper providing recommendations that have been described in this paper
designed to improve care delivered from the systems level (Eiseman et al., 2012). The
literature verified that not initiating treatment post fracture would result in a poor
outcome (Eisman et al., 2012; Marsh et al., 2011). The FLS model of care focuses on
early identification and treatment initiation post fracture. In a prospective observational
study, Kates and colleagues (2012) examined 562 hip fracture patients and found that
32% of patients with hip fracture who were not treated with a bisphosphonate were
readmitted to the hospital within the first year. Subsequently, Kates and colleague also
showed that the initiation of a fracture management program, including early initiation
and monitoring of treatment post fracture, reduced readmission rates due to re-fracture to
10.3%. Thus, a coordinated program that used a coordinator and a coordinated IT system
could reduce the rate of re-fracture by preventing fracture. Kates and colleagues
attributed their success in improving patient outcomes to early treatment initiation with a
bisphosphonate and patient monitoring of the treatment. However, no studies identified
how to overcome barriers such as PNA.
In 2003, Boockvar et al. found similar results in an observational study in which
they confirmed that patients who were not adequately treated post fracture were often re-
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hospitalized and had bad outcomes. Both Boockvar et al. (2003) and Kates et al. (2012)
found success in implementing similar FLS techniques of early treatment initiation and
monitoring of treatment adherence compared to those organizations without a program in
place. Information technology makes it possible to monitor large and growing
populations of patients that cannot be done by hand in a paper-based system; thus, a
computer is a necessary component (Che et al., 2005; Cheetham et al., 2013; Dell, 2011).
Use of an FLS coordinator-based program has been shown to have some of the solutions
but there are limitations. One of the limitations is FLS programs have not been able to
connect all of the necessary components to close all care gaps such as PNA. It is
important that solutions be found to this problem and those solutions must be translated
into practice.
Primary non-adherence (PNA) has been discussed as being caused by failures at
the patient, provider, or system levels. Literature supported programs that incorporate the
FLS model of care, telephonic outreach, EMR, and integrated pharmacy systems as
necessary components of a successful disease management program. To date, attempts
have been made but no one has been able to integrate all needed components (Kastner &
Straus, 2012).
In spite of studies (Gadkari & McHorney, 2010; Giangregorio et al., 2008;
Greenwald & Farnham, 2000; McHorney & Spain, 2011; Sale et al., 2011) on primary
non-adherence to bisphosphonate medications, major inconsistencies in evidence and
definitions regarding compliance have made it difficult to compare them. Additionally,
lack of consistency in study results and lack of systematic reviews have further
compounded addressing the issue of PNA. Commonly, studies use small population
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sizes, making generalizability difficult. After an extensive literature search, it was found
that for such an important issue, very limited information was available on PNA in
general. Methodological limitations included use of self-report questionnaires in some
studies compared to predictive models that used past behavior data to predict future
behavior. Many of the studies identified problems but did not give solutions. Reynolds
et al. (2013) identified the problem of a 29.5% PNA rate in the program they studied but
offered no solutions of how to improve on it. Given this limitation, it is important for
studies to focus on solutions and make recommendations for possible future studies.
The literature consistently showed that patient education techniques alone do not
work and have failed miserably in affecting outcomes (Eisman et al., 2012; Solomon et
al., 2003). The only benefit seen was patients learned that osteoporosis is a serious health
condition and it might have serious health consequences, but it did not improve patients’
ability to connect osteoporosis and hip fracture reduction to their medical treatments
(Solomon et al., 2003). Additionally, Cook et al. (2007) found that patients’ reasons for
not picking up medication usually had a psychological aspect such as fear of side effects
and needing to overcome denial of having a chronic condition, feeling the medication
was not important, that they did not need the medication, and that they did not want to
spend the money on it because they believed a good diet was sufficient to prevent
osteoporosis. Many patients, even after extensive medication education, still did not
adhere to taking it and stated that although they understood osteoporosis is a serious
condition, they did not make the connection between osteoporosis and the fracture and
how the medication would prevent fracture. The main limitation of the literature was the
studies did not give solutions to how the problem of PNA could be resolved. Although
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informational, the articles especially did not provide recommendations that could be
translatable into practice.
Another study (Siris et al., 2006) confirmed that when patients do not have
symptoms, they do not feel motivated enough by education about the disease to take a
medication. Since osteoporosis does not have a symptom until the fracture event,
patients do not always understand the importance of taking their medication. The
literature had direct application to this capstone project because patients who are screened
for osteoporosis might not understand the importance of taking their bisphosphonate
medication because they do not have symptoms until the fracture event and sometimes
after the fracture has occurred. Although health education is an important topic, it should
be left to health educators. Teaching classes is not the best time spent by the NP health
provider when patient identification, risk stratification, treatment, and follow up have
been shown to be more effective. Bisphosphonate treatment is the most effective way to
reduce a person’s risk for fracture. However, if they do not take the medication, they do
not get the benefit of fracture risk reduction.
Summary
Primary non-adherence (PNA) has been discussed as being caused by failures at
the patient, provider, or system levels. Literature supported programs that incorporated
the FLS model of care, telephonic outreach, EMR, and integrated pharmacy systems as
necessary components of a successful disease management program. To date, attempts
have been made but no one has been able to integrate all needed components (Kastner &
Straus, 2012).
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The literature has shown that patients with a first time prescription for a
bisphosphonate were not all picking up their medications. This problem has sparked an
interest to develop a system and protocol that could be applied to improve PNA.
Evidence-based guidelines are ineffective unless they are implemented and the evidence
must be translatable into practice. The implementation of an osteoporosis disease
management program, especially if an electronic health record is used, is an effective tool
in lowering the hip fracture rate. Through the use of clinical practice guidelines and
guidance practice of the staff trained with TBP, acceptance and implementation of such
systems would facilitate changing current provider behaviors. The literature did not
clarify all factors concerning the reasons for PNA. There is still much confusion and no
standardization of terms and definitions, which makes describing the problems and
solutions difficult to compare between studies. This capstone project implemented a
protocol for which outcomes were measured to determine its effectiveness in addressing
the problem of medication adherence in patients with osteoporosis. Once standardization
is established, other researchers can build upon it instead of recreating and applying new
terms to what has already been established.

CHAPTER II
STUDY DESCRIPTION AND OBJECTIVES
Study Description
Primary non-adherence (PNA) to bisphosphonate medication is a growing
problem that needs to be addressed by an osteoporosis/fracture prevention/disease
management program. Hip fracture reduction goals can best be achieved by having all
the care gaps easily identified with the help of information technology tools. These tools
incorporate all the clinical practice guidelines of the organization’s osteoporosis/fracture
prevention program and automate the steps to identify all patients who have a care gap
related medication non-adherence. Not taking a prescribed bisphosphonate increases the
risk to the patient for future fractures. By developing a procedure reflecting the most
recent research evidence, the Doctor of Nursing Practice (DNP) student wrote a protocol
for telephone outreach in collaboration with organization leaders to improve the
incidence of primary non-adherence to a bisphosphonate.
Objectives of the Study
Two objectives were identified in this study. The first was to develop and
implement a protocol to target patients diagnosed with or at risk for osteoporosis and hip
fracture who had not picked up their bisphosphonate medication from the pharmacy
within 60 days. The second objective was to decrease the current rate of PNA by 20%
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from its identified rate of 29.5% in order to be clinically significant during the study
period, which spanned four months.
Study Design
This prospective observational study was designed to determine the effect of
using an information technology tool at the facility to systematically identify all patients
at potential risk of becoming non-adherent to their anti-osteoporotic medications over a
period of 60 days. The data collection lasted approximately two months (n = 216); the
study followed each patient for 60 days or until he/she picked up the medication. The
care manager at the medical facility was a nurse practitioner (NP) and was part of the
program. She provided the patient care and coordination. This study used the Reynolds
et al. (2013) article as a benchmark in setting a goal of using approximately 216 patients
in an attempt to lower the rate by at least 20%.
The program uses a systems-based approach to disease management to monitor
and change a course of action. Applying the theory of planned behavior (TPB) to guide
patients’ decisions to develop an intention to pick up and then take their medication, the
nurse practitioner (NP) used a telephone outreach protocol to enhance communication,
build rapport, and assist patients in getting the information necessary to resolve issues
leading to non-adherence. Adoption of this method allowed for improvements in
efficiency and effectiveness and maximized the time to accomplish it as expediently as
possible. This method enables researchers to apply the same protocol to each patient
equally and minimize disparity (Navarro, Greene, Burchette, Funahashi, & Dell, 2011).
The NP used the protocol to guide the practice in the right direction. Productivity was
monitored and measured to maintain a course of action and adopt the new protocol.

50
Setting and Study Population
The study included all patients aged 55 and older who had a new prescription for
a bisphosphonate medication and no history of ever having a bisphosphonate prescribed
to them. The patients were entered into the disease management registry and had a dual
energy X-ray absorptiometry (DXA) scan or a diagnosis of osteoporosis that was not
exclusionary.
Patients were excluded for the following reasons:
1.

Patients who were not Health Maintenance Organization (HMO) members
or who had died or been terminated from their insurance.

2.

Those patients who had a history of taking a prescription or had taken a
bisphosphonate in the past.

3.

Patients with chronic kidney disease (CKD) 4 or 5 or if they were on
dialysis.

4.

Patients with diagnosed hypocalcemia.

5.

Patients with allergies or other contraindications to taking a bisphosphonate.

Patients who were excluded at any time were not carried through in the data base
tool population for the purposes of this study only.
The study setting was an NP-led disease management program. The following
patient demographics were currently in the system and were extracted from the
department for use by the program: (a) age, (b) race/ethnicity, (c) gender, (d) diagnosis of
osteoporosis (if there was one), (e) score from DXA scan, and (f) diagnosis of a fragility
fracture (hip, distal radius/ulna, spine, humerus, pelvis, and other femur). All were
confirmed to have a prescription for a bisphosphonate.
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Background of the Fracture Liaison
Service
The program began in 1998. It has a 16 year history of using teams and
technology in reducing fracture rates and saving money. This study’s focus was the role
information technology tools played in translating evidence into practice in order to
improve patient outcomes. Current practice protocols reside in the osteoporosis/fracture
prevention clinical practice guideline (CPG). The organization’s 3.7 million members’
records are automatically updated every day with the use of the Knowledge Builder Tool
(KBT). The KBT automates the steps in patient enrollment, applies the rules of the CPG
protocol, and determines actions needed. Patient data are displayed as well as actions
needed in a secure, password protected, and user-friendly interface. The system receives
feedback from the program nurse practitioner (NP) care managers when they work within
guidelines developed to close care gaps.
The average care manager spends several hours a day searching for patient data or
screening patients to determine each patient’s appropriateness for the program (Dell,
2011). It is very time consuming for the NP to search data in order to generate
appointments for patient encounters or to conduct program outreach operations. The
KBT cuts down tremendously the amount of time it takes for someone to manually search
for information. Thousands of records can be sifted by the computer and an updated list
can be generated on a daily basis, thus allowing the NP to work the list, organize time,
and set priorities more efficiently. The time it takes for the KBT to run a report on 3.7
million records is the approximate time it takes for a NP care manager to review one
complete patient chart. The power and speed of this tool is unmatched by anything that
can be done manually (Dell, 2011).
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This medical center has run previous pilot projects and was the first site to roll out
implementations to address care gaps in osteoporosis and fracture prevention. This site
volunteered to be the beta testing site of the new tool to address PNA and was the site to
implement this study. The patient intervention group had data collected on
bisphosphonate prescriptions and tracking of dispensed bisphosphonate medications.
There was no control group. The number of days from the time the medication was
prescribed to the day of pickup was tracked and measured within a 60 day period using
percentages and a questionnaire. A Likert scale for the interview questionnaire measured
NP beliefs before and after the intervention and patient beliefs were measured by a yes/no
questionnaire in the form of a telephone outreach tool.
Description of the Knowledge Builder Tool
The Knowledge Builder Tool uses an SAS-based 9.2 program with Enterprise 4.3.
There are many advantages of using the SAS version of the Knowledge Builder Tool. It
is a far superior development platform for disease management registries used by all the
health plan organization’s sites. The KBT is built from a toolkit of over 1,000 modules
and is able to capture data from laboratory results, diagnostic tests, clinic visit notes,
hospitalizations, surgical history, and other data housed in the clarity data warehouse
(CDW). Data are updated on a daily basis. The chosen data components are downloaded
daily into the disease management program and patients are placed onto a list worked by
the NP care manager. The various parts of the registries can be used by NP care
managers to manage a patient’s care gaps (Dell, Loo, & Loomis, 2012). For example, the
FLS team recently started implementing the new osteoporosis/fracture prevention clinical
practice guideline (CPG) as well as several new guidelines addressing such things as drug
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holidays for bisphosphonates and re-DXA schedules based on the last DXA result. New
recommendations to address primary medication non-adherence are currently being
updated and added (Kanter, Lindsay, Bellows, & Chase, 2013).
The KBT began as a disease management registry in 2011 and since has expanded
to incorporate clinical practice guidelines in an interactive and dynamic data registry tool
that can address all care gaps and patient needs programmed into it (Dell et al., 2012).
The registry is updated on a daily basis from the CDW described earlier. For example, a
patient with a need for screening will be targeted as “needs DXA” so the NP will receive
a list with all needed information so this care cap can be addressed. For the PNA tool,
the same thing applies. All care gaps are decided upon by the program and become
strategic goals. On a yearly basis, the data are matched with existing guidelines to ensure
the guidelines are being followed.
By using the KBT, it is possible to convert the rules inherent in the new
osteoporosis/fracture prevention and CPG into modules that capture certain rules and
apply them. The FLS nurse practitioner care manager is able to see the daily updated list
of patients who have one or more of the care gaps and address each. For the purpose of
this project, they addressed the care gap of primary non-adherence (PNA).
The KBT is built with knowledge builder modules that have global variables to
allow SAS developers to very quickly change the variables to see the medications and
monitor them, as in the case of bisphosphonates. This program tracks all patients with a
certain diagnosis, such as osteoporosis, or a prescription for a certain drug; it searches the
CDW to find which patients are prescribed this medication or have this diagnosis and
then downloads the information to the NP care manager. According to Che et al. (2005),
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closing care gaps and using measures, such as healthcare effectiveness data and
information sets (HEDIS) to determine how to stay compliant with meeting quality
measures, are important components in identifying and closing care gaps, especially in
the prevention of fragility fractures such as hip fractures--one of the most debilitating of
all fractures. The tool was originally developed as a part of the organization’s safety net
project where it was extensively tested and validated. The KBT program applied lessons
learned from previous studies and developed useful guidelines, such as osteoporosis with
this intervention study.
The Complete Care program, also sometimes referred to as Safety Net Project,
provided a care framework that changed systems within the organization in many ways
across multiple levels and provided an avenue for validating the KBT. An article by
Kanter et al. (2013) showed examples of the care teams who used clinical decision
support of the KBT and how it was integrated across different sites. This article
described how the tool was accepted and validated. Work on this project was undertaken
to break down care silos and act as a way to provide aggressive outreach/care
management services for individual patients as needed to achieve care goals and close
care gaps (Kanter et al, 2013). The KBT was validated through many studies.
The KBT was developed so it could be interfaced with the electronic medical
record (EMR) to target and close specific care gaps in various disease management
programs within the system. An information technology tool based on Drools Guvnor
(Dell et al., 2012.) software was selected to be the foundation and the principle rule upon
which the Knowledge Builder Tool (KBT) was built and validated. The KBT is basically
a relational database management system that can be transformed into a database system
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according to an individual user’s needs. Access to the KBT is controlled and password
protected; it is possible to lock down and restrict access so only approved individuals can
view and make edits. The tool is automated and includes internal components of decision
making. This enables providers to focus on treatment and follow-up by having
information readily available
Ethical Considerations
Institutional Review Board
Since this was not an experimental study, exempt review was sought and obtained
from the Institutional Review Board (see Appendix A). Each participant signed a consent
form agreeing to participate in this research study (see Appendix B). There was no
experimental or control group. The DNP student researcher did not have any direct
contact nor made telephone calls to patients. This was the responsibility of the
organization’s nurse practitioner care manager. The NP coordinated all care related to
the management of the patients. The student researcher directly communicated with the
care management team and staff members for the duration of the study. All ethical and
legal considerations were observed with respect to privacy of patient electronic medical
records. The DNP student researcher obtained Institutional Review Board (IRB)
approval from the HMO where the study was conducted (see Appendix C). The DNP
student reviewed chart records to gain information and track patient performance.
Patients were given anonymity through the use of a unique identifying number and to
prevent duplication. All patient information was encrypted and password protected and
all information in the records was protected to the highest level of security as possible.
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All patients were notified that they were being enrolled in the FLS program--a
regular component and service provided by their health plan. They were not coerced or
forced to participate in any way. All patients were given an opportunity to refuse to
participate. Patients who chose not to participate were marked as PNA and removed
from the study. If at any time the patient had a change of interest, he/she was easily
added to receive the full services the FLS program had to offer them. Patients who
dropped out of the program were encouraged to follow up with their primary care
provider (PCP) in order to have access to an ongoing continuity of care. All patient
privacy was upheld by the laws of the organization and all state and federal laws such as
Health Information Privacy and Accountability Act (HIPAA) were observed. Patient
information was not shared outside of the study’s environment.
Memorandum of Understanding
The Memorandum of Understanding (MOU; see Appendix D) was an agreement
between the DNP student researcher and the organization. The role of the DNP student
and involvement with the study were outlined as follows:
1.

The DNP student would actively work with staff members in the FLS
program, the physician champion, the information technology department,
and leaders and front line care managers from the Osteoporosis/Fracture
Prevention Disease Management Program.

2.

The new protocol as written provided a framework for NP practice. The
DNP student trained the NP regarding the protocol steps and the theory
behind it. Training was for the purpose of increasing the NP's knowledge
base and improving her ability to integrate and disseminate the new protocol
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successfully. This was done during a face to face meeting with senior
leadership in December of 2013.
3.

The DNP student would work with the existing staff of the program. There
was no direct patient contact by the student.

4.

The organization would like to be referred to as a large HMO in Southern
California.

5.

The DNP student researcher would interface with staff members and
physician champion and have access to patient records only. There was no
direct contact of the student researcher with patients. The student attended
meetings by phone and face-to-face and was onsite for specific meetings.
Most interaction was by telephone or email. All patient information was
kept confidential and this study had already received organization approval
(see Appendix C).
Goal of the Study

The study goal was to align and advance current nursing practice with the best
available evidence and current clinical guidelines for osteoporosis chronic disease
management and fracture prevention with the goal of improving the existing PNA rate by
20%. This study measured changes in PNA rate through the implementation of a
telephone outreach protocol. Other healthcare delivery systems might see the benefit in
implementing an FLS program and use similar systems to meet various goals and close
all existing care gaps. Additionally, the basic design of this tool was compatible with the
software being used and could be generalized to many different settings.
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Desired Outcomes of the Study
Attitudes and Behavior
The theory of planned behavior (TPB) specifies the nature of relationships
between beliefs and attitudes. A person’s evaluations of or attitudes toward behavior are
determined by their actions and behavior. A belief is defined as the subjective
probability that the behavior will produce a certain outcome. The theory of planned
behavior's positive evaluation of self-performance of the particular behavior is similar to
the concept to perceived benefits, which refers to beliefs regarding the effectiveness of
the proposed preventive behavior in reducing the vulnerability to the negative outcomes,
whereas their negative evaluation of self-performance is similar to perceived barriers.
In this study, the NP acted as the change agent--the entity who causes the change
to occur (Rogers, 2003). By implementing the protocol, the NP began an action that was
predicted to bring about positive change in the patient’s behavior. The goal was to get
patients who had not picked up their medication after 14 days to change their intention,
then change their behavior, and pick up the medication. It was believed the telephone
call would be instrumental in changing the patient’s behavior. Patients were asked
questions during the call, which in turn measured their responses and beliefs. The NP
was a critical component in the process of changing the patient’s behavior from not
picking up the medication to picking up the medication from the pharmacy. It was
important for the NP to have positive feelings, attitudes, and beliefs about her individual
influence and control to effect change in each individual patient she encountered.
Behavior and behavioral intention are defined as follows:
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Behavior. An individual's observable response in a given situation with respect
to a given target. Ajzen (1991) said a behavior is a function of compatible intentions and
perceptions of behavioral control; perceived behavioral control is expected to moderate
the effect of intention on behavior, such that a favorable intention produces the behavior
only when the perceived behavioral control is strong.
Behavioral intention. An indication of an individual's readiness to perform a
given behavior. It is assumed to be an immediate antecedent of behavior (Ajzen, 1991).
It is based on attitude toward the behavior, subjective norm, and perceived behavioral
control with each predictor weighted for its importance in relation to the behavior and
population of interest.
Self-Evaluation Questionnaire of the
Nurse Practitioner
Below is an example of the way NP beliefs data were collected to determine her
state of beliefs and attitudes before and after the staff education regarding the theory of
planned behavior (TPB) and its application to the study (see Figure 2). The telephone
outreach tool was presented to the NP and her opinions and beliefs were measured. The
NP was asked to rank the responses of her beliefs before and after the study (see
Appendix E for the NP questionnaire).
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The NP is presented with the information about
the problem of PNA in her patient population and
is told that a change is coming

NP has an attitude existing about risk verses benefit
And an attitude about preferences/biases related to this topic
The NP has had some success with change in the past

Normative/Subjective Beliefs
The NP realizes that participating in this it is expected by work
colleagues and it is the right thing to do peers
The NP receives training and gains more information about the
needed change and the protocol itself. Evidence is presented to NP.

Behavioral intention is developed by the NP. The NP then acts as
Change agent and gets the patient to develop intention and then
change behavior.

Perceived Behavior Control
Result is that the desired change in behavior or belief
occurs in the NP first and then the patient. The
patient then acts and picks up the medication
and action is taken.

Figure 2. Flow diagram of how the theory of planned behavior effects change in
attitudes and behavior of patient and nurse practitioner.
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Evidence
Both patient and NP responses were yes/no on the tool and then further broken
down on Likert scales to show specific effect and strength on behavior change. The
evidence being collected for this project was the patient and NP beliefs before and after
the intervention. This was analyzed and based on TPB principles. The principles of TPB
that influence intention development and behavior change were normative, subjective,
and perceived control and are described as follows:
1.

Subjective norm: The belief that the person is doing the right thing.

2.

Social norm: The belief that the behavior is what is expected of them to do
by others such as peers or superiors.

3.

Perceived behavior control: The belief that the person has control over the
ability to make the change happen.

The patient evidence was collected from the feedback from the telephone calls, patient
responses, and the outcome showing the patient picked up their medication or not. The
NP behavior was important but only as it facilitated patient behavior change.
Evidence-Based Study Intervention
This study used a theory-based protocol developed by the DNP student and given
to the staff of FLS program, specifically the NP. This protocol was intended to improve
the staff’s knowledge, self-efficacy, and skills concerning PNA. Using the protocol, the
NP acted in the role of change agent. This action of calling the patients would effect
change in patient behavior and as a result, a change in intention and behavior would
occur, thus improving outcomes in PNA. The study plan was to investigate the impact of
implementing an FLS program telephone outreach protocol on the rate of PNA. The goal
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ws to lower the rate of primary non-adherence by 20% within a two month period.
Studies have shown this to be a feasible and cost effective goal (Che et al., 2005; Dell &
Greene, 2010; Eisman et al., 2012; Kates et al., 2010; Reynolds et al., 2013; Solomon et
al., 2014). The theory of planned behavior was used as a theoretical framework to guide
practice and the beliefs of the providers and the patients.
Information technology and NP care managers systematically identify and target
patients who are at risk for PNA. The outcome would be to prevent them from
progressing to PNA. This plan began from a need for an intervention to assist patients to
pick up their bisphosphonate medication. Previously, no action or intervention has
worked with patients who did not pick up or take their bisphosphonate medication. A
protocol was developed and tested that identified patients who had not picked up their
medication within 14 and 60 days. The nurse practitioner (NP) received a list of patients
from the computer and then worked the list by calling each patient on the list at different
increments of time such as at 14, 30, and 45 days. During each telephone outreach call,
the NP used a protocol that consisted of a series of questions to identify why the patient
did not pick up the medication. The NP used an evidence-based solution to change the
patients’ intentions to get them to pick up and take the medication, which they would not
have previously done without the intervention. The protocol demonstrated how the
theory of planned behavior (TPB) concepts was used as a basis for change in patients’
behavior related to primary non-adherence (PNA). The effects of the protocol, developed
using evidence-based guidelines and TPB on the patient’s intention and behavior change
to pick up and take their medication, were measured. The NP applied concepts of TPB to
address patient beliefs and guide behaviors regarding taking their medications. The NP
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addressed each factor and evaluated what could be done to get the patient to pick up the
medication. For patients in the study, the reasons why they did not pick up the
medication and action by the NP were noted.
The following NP actions were taken during the implementation of the protocol
and evidence was collected during the telephone outreach protocol (see Appendix F):
1.

The NP answered patient questions and engaged in education as needed.
Effective communication was evidenced by patient answering a
questionnaire during the call.

2.

The NP made an appointment for patient to come for a face-to-face care
management visit.

3.

The NP changed the medication if the patient did not want this one. For
example, the patient might need to have the medication changed from a
weekly to a monthly dosage.

4.

The NP removed patient from the list if patient refused to take the
medication or just did not want to be called. Patient was referred back to
PCP. If the time went past 60 days and patient did not pick up the
medication, then he/she was PNA.

5.

If patient concern warranted a switch of medication because of a medical
contraindication, medication was stopped until specialty approval was
given.

6.

The NP referred the patient back to the PCP or specialist for any concern or
any reasons deemed necessary by NP.
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The plan for educating the staff was described including content, strategies for delivery,
and using TPB as rationale for specific strategies to change staff behavior.
A face-to-face meeting was held in December 2013 for the purpose of staff
education and orientation. At the meeting, the Reynolds et al. (2013) study and its results
were discussed in detail. The staff understood that this study was being used as a base of
comparison or benchmark. At this meeting, goals for PNA were set at a reduction of
20%. It was decided that a pilot site would begin developing a protocol. A second
meeting was held on May 20, 2014 where the staff was given information about the
protocol questions, more on the TPB and self-efficacy, and the importance these theories
would have to the study. This site volunteered to be the pilot and testing site. However,
although all staff received information about the study, only one NP implemented the
protocol. The student researcher developed the protocol along with the NP and the
physician advisor. Prior to this, no protocol was in place. The telephone outreach
protocol was discussed completely at this meeting. The study design was discussed and
the NP agreed to do this.
Plan for Staff Education and Training
The plan for educating the staff included content and strategies for delivery that
used TPB as a rationale for specific interventions, which led to a change in staff beliefs
and behavior. The staff consisted of one nurse practitioner from this site. Other staff
members working with the FLS program at other locations had access to the information
and training but did not participate in the actual study. All FLS program staff were
educated to the changes and implementation of the PNA study. This training was only in
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anticipation of expanding this program to other health organization sites. Staff were
given a copy of the protocol and information related to TPB.
The development of translatable knowledge involved steps that first identified
patients with a care gap related to not picking up a new prescription medication from the
pharmacy. It was important to risk stratify this population into groups that need specific
care gaps, in this case--primary non adherence (PNA) to prevent a bad outcome. This
systematic approach was the best way to manage the care gap of PNA as well as track
patients over time. The NP care coordinator took responsibility to take appropriate action
to get patients to change their behavior through a coordinated program that would result
in better adherence to treatment recommendations. The protocol and care plan included
information technology tools that would help in the care being delivered. The care team
needed to be all on the same page including the patient who must be considered as a
member of the team.
Budget and Financial Disclosures
The resources used were the existing staff of the FLS program. The existing staff
implemented a telephone outreach protocol to call patients who had not picked up their
prescription medications at different incremental time periods. The staff used existing
departmental space and computer equipment they used every day in their regular job
function. No new budget was created. As appropriate to the individual study and
determined by the advisor and mentor, the DNP student included a market analysis,
strategic analysis, product/services, or financial plan that justified the need, feasibility,
and sustainability of the study (see the financial impact section in Chapter I).
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There was no set budget for this research study. The DNP student researcher was
a non-paid volunteer and not an employee of the organization. This was not a grant
funded project. There was nothing financial to disclose and there was no conflict of
interest. This program was designed to be self-sustainable. The whole disease
management team was involved in the education and planning of this project including
all managers, physician champions, and NPs at all other organization sites. These staff
members were educated to the PNA protocol because it was planned to be expanded to
their sites after it was first implemented at the facility. Other staff members were aware
and updated but were not involved. It was predicted that the final results of this project
would prove to be a cost savings to the organization. Studies have shown that nonadherence to mediations is costly to the organization and to the healthcare system in
general. Patients do not benefit from medications not taken. This problem could result in
serious consequences and bad patient outcomes.
Primary Non-Adherence Workflow Process
for Telephone Outreach
The process of using the information technology tool to identify patients who had
not picked up their medications within 60 days involved the NP receiving a list of
patients each week who had a prescription and had not picked up their medications. The
NP called the patients at 14 days. After 14 days, the NP documented whether or not she
had been able to reach the patient and the response. At 30 days, the patient was called
again and an internal message sent to the primary care physician (PCP) that the patient
had not picked up the bisphosphonate prescription from the pharmacy. Then after 45
days, the patient was called again and a letter sent to the patient encouraging them to
make an appointment to follow up with their PCP. For the purpose of the FLS program,
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the patient stayed on the list until the NP took them off and they remained on the list for
further follow up. However, for the purpose of this study, the patient was no longer
followed after 60 days and was considered PNA (see Figure 3 for diagram and letter sent
to patient and provider in Appendix G).

Figure 3. Timeline for protocol.
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The Study and Agency Strategic Plan
The organization desired to have a strategic plan in place to lower patients’ risk of
hip fracture through early identification, risk stratification, treatment initiation,
intervention, and follow up of patients. Many of the patients (29.5%) targeted with a
bisphosphonate treatment were not picking up their medication from the pharmacy. This
identification sparked an interest in developing a protocol to improve the rate of primary
non-adherence (PNA) to a new prescription for a bisphosphonate with the overall goal
being improved patient outcomes through less hip fractures.
The plan in this study reflected how the concepts in TPB were used as a basis for
strategies in the protocol that was developed. This included an example of the strategies
that impacted patient beliefs regarding taking their medications. This was evaluated by a
Likert scale developed by Morisky, Ang, Krousel-Wood, and Ward (2009) who were
able to show that adherence to medications could be evaluated through six domain topics:
(a) knowledge, (b) attitude, (c) , (d) social support, (e) stress, (e) coping, and (f)
medication complexity. The new protocol fit within the existing framework of the
organization’s policies for the FLS program. Primary non-adherence was considered a
new care gap that must be closed. The Knowledge Builder Tool (KBT) is a computer
system that has each care gap listed inside. The NP clicked on the list of patients who
needed an intervention and then proceeded to work the list according to the clinical
practice guideline embedded under each specific topic. In this case, it was the
development of a new protocol to improve PNA in patients with a new prescription for a
bisphosphonate.
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The telephone outreach tool questionnaire has been piloted. Nor has this specific
situation ever been studied. However, the questions were developed from a validated
tool to measure medication adherence in an outpatient setting (Morisky et al., 2008). The
outreach tool was based on the domains derived from the Morisky tool. Each question
was developed to relate to one of the following domains:
1. Knowledge
2. Attitude
3. Social support
4. Medication complexity
5. Stress
6. Coping.
Timeline of Study Phases
The timeline was four to five months in duration--two months consisting of
patient enrollment, approximately two additional months to conduct the study, and one
additional month to analyze and prepare the results. Each patient in the study was
followed for 60 days or until he/she picked up the prescription from the pharmacy. The
study began when the initial proposal was accepted by the researcher’s doctoral
committee and the proposal was been approved by the University of Northern Colorado’s
Institutional Review Board (see Appendix A). Then the following phases were
implemented: (a) recruitment phase was two months, (b) protocol implementation phase
was 60 days for each patient enrolled in the study, (c) data collection phase lasted 60 days
for each patient recruited, (d) data analysis began two weeks after the data were all
collected, and (e) evaluation phase was congruent with the two weeks of the data
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analysis. Evaluations were ongoing during the study while NP evaluation data collection
sheets were being filled out (see Table 1).

Table 1
Timeline of Phase Implementation
Phases

Activity Conducted

Timeframe for Phase

Recruitment

216 patients will be enrolled
in the study. The protocol
and how data and phases
will be measured have been
explained to the NP.

2 months. The first 2 months. Starting at
the day the medication is written the
patient goes on the list.

Protocol implementation

The patients will be
identified as not picking up
the medication and will be
called and protocol applied.

Day 14 of each patient not picking up
medication.
This will run 60 days for each patient.
Starting at the first day of medication
prescription. Action by NP starts at day
14.

Data collection

Telephone outreach tool
will be applied.

This will run for 60 days for each patient
starting at the first day of the
prescription.

Data analysis

The outcome of the
telephone encounters is
applied and data were all
collected.

Two weeks after data collection phase
ended

Evaluation

The results will be reposted
and all actions are evaluated

This will take two weeks to begin at the
end of the data collection phase.

Note. The shortest possible time would be three months and longest time would be five months depending
on the rate the patients picked up their medication.

All patients with a new prescription for a bisphosphonate were eligible to be
enrolled. Both men and women over the age of 55 years with a new prescription for a
bisphosphonate were included. This age of 55 and older was chosen because it was
directly comparable to the Reynolds et al. (2013) article that discovered the problem of
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PNA at the facility. The only difference was men were also included in this study since
the Reynolds et al. study included only women.
Bisphosphonates used in the study were Alendronate, Residronate, and
Ibandronate. The NP could see in the computer system the prescription and the
medication prescribed. However, they were marked only as bisphosphonate for the sake
of this study. All prescription orders were placed electronically so all prescribed
mediation data were captured in the system electronically. The data were stored in the
organization’s pharmacy information system (PIMS) and also housed in the clarity data
warehouse (CDW). The medication prescription information was updated once daily and
downloaded into the system. Patient information data were also downloaded to the
disease management registry for all patients in the facility’s pharmacy. These systems
interfaced with the disease management registries through the existing electronic medical
record (EMR). These interfaces allowed access to secure patient data of all new
prescriptions for a bisphosphonate and whether a prescription order was picked up.
Additionally, if orders were discontinued, cancelled, or changed by the prescriber, or the
patient was terminated as a member, this was also noted in the system. No prescriptions
for bisphosphonates were written on paper. The name of medication might have been
populated but for this study, it was yes or no if the patient had a prescription for a
bisphosphonate. There was nothing to collect other than the NP acknowledged looking at
this information and the call was placed to the patient during the appropriate period of
time such as 14 days, 30, and 45 days. The NP communicated with the researcher on a
weekly basis.
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Descriptive Statistics
The mean was calculated to determine the average age and average time interval
the prescription was either picked up or not from the pharmacy. The statistical analysis
determined the interpretation of results and showed whether or not the goal was met.
Statistical significance of and differences were determined.
Absolute risk reduction (ARR) is also called risk difference (RD). Absolute risk
is a very accurate way of presenting research results and help with decision-making. In
this example, the ARR of 6% equated to a relative risk reduction of 20%. This meant
that if 100 patients were treated, six would be having PNA to see a 20% reduction in the
group. Relative risk reduction (RRR) tells how much the treatment reduced the risk of
bad outcomes of one person relative to the control group who did not have the treatment.
The relative risk included everyone in the intervention group as compared to the control
group.
Power analysis was necessary to determine whether the sample size selected was
adequate. In this case, a power analysis determined it would be necessary to have 216
patients to represent a sample size that could be generalizable to the population. The
sample size and findings were designed to be statistically and clinically significant in
order to be representative and show an improvement in the PNA rate, which was the goal
of the program. It was decided to run the study for two to three months to have enough
patients because men were included in the study.
The Reynolds et al. (2013) study was used as a benchmark because it showed the
incidence of occurrence in this study population to be 29.3%. The data were useful
because they were selected and used from the same population. It was decided by the
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research team that data collection for the span of two months would be adequate in
generating the sample size needed to show statistical significance (n = 216).
Data Collection Method
The data collection method with the use of this tool was through an interactive
website that interfaced with the clarity warehouse wherein patient data were updated on a
daily basis. Most of the data were already stored within the EMR. The NP collected data
from the telephone encounters.
Measures/Instruments
The measurements were taken and recorded by the NP into the Knowledge
Builder Tool (KBT) embedded into the disease management registry. All patients with a
new prescription for a bisphosphonate were included in the study (n = 216) and the rate
of PNA was measured after 60 days of patients not picking up their prescription.
Variables Measured
A dependent variable depends on the independent variables. In this case, the
dependent variables were medication adherence and primary mediation non adherence.
An independent variable is a variable that has an effect on the outcome. Its value
determines the value of other variables. For example, it stands alone and is not changed
by the other variables being measured. An independent variable causes some kind of
change in the other variables, such as dependent variables. Six independent variables
were identified in this study. The following variables were not collected by the NP since
they are already in the in the KBT to assist the NP with information if needed and to help
the NP determine that the patient was eligible for the program. They were analyzed at
the end of the study to report on the characteristics of the patient who was PNA versus
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adherent to bisphosphonate therapy. The data added value to the analysis of the results.
It was important to understand the characteristics of the patient who is adherent versus
primary non-adherent.
Age. The age of the target population was set at 55 and older. Age was measured
in years and months. The reason to use age and 55 or older in this study was to make the
data more comparable; the number 55 was selected mainly in an effort to improve the
rate of PNA. The Reynolds et al. (2013) article found that age as a characteristic affected
adherence risk and was used as a predictive variable. The more closely their
characteristic could be matched with our study population, the more significant the
findings.
Gender. This study population included men and women. Men and women were
selected because not much is known in the literature about men; this population has been
historically underserved with osteoporosis diagnosis and treatment. The population size
was large enough so women could be directly compared to women in the comparative
study with Reynolds and colleagues (2013). Then our own women data could be
compared internally with our male data to gain more knowledge and insight into men
being characteristically more, less, or the same as women when compared in this setting.
Characteristic of prescriber: Nurse practitioner or primary care provider.
Characteristics of the prescriber were assessed and compared to similar characteristics in
the Reynolds et al. (2013) study. It was thought that PNA could be predicted when
certain characteristics of the prescriber were known. In this study, only the characteristic
of whether it was the NP care manager or the PCP who generated the prescription was
collected and compared since these data were comparable. For example, if the
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prescription was written by the NP care manager, then the patient would have received
program interventions such as education and face-to face-counselling with the NP that
might not have occurred if the prescription was not written by the NP. This factor was
not as well controlled when the prescription was not ordered by the care manager.
Medication teaching might vary from provider to provider if not implemented from
within the program protocols, guidelines, and policies. The NP did not collect these data
as discussed earlier. It was important to see if there were similarities related to the
characteristics of the prescriber and patients who had PNA or were adherent.
Summary
In summary, this capstone project implemented a protocol for which outcomes
were measured to determine its effectiveness in addressing the problem of medication
adherence in patients with osteoporosis. This project was a population based study (n =
216) that implemented an information based tool to reduce the rate of PNA by 20% from
the current rate seen in this population. The study was a prospective, observational
analysis and includes all out-patient men and women in the program age 55 and older
with a first time prescription for bisphosphonates.
The evidence-based telephone outreach protocol was fed by the KBT to provide
the NP with a list of patients who needed a call. The protocol was implemented by the
NP as part of an existing osteoporosis disease management program (ODM). Statistical
analyses calculated and measured the variables, compared them to each other, and then
determined whether or not the use of the tool was the reason for meeting the goal of a
20% reduction in the PNA rate.

CHAPTER III
STUDY EVALUATION PLAN
This was a prospective, observational study conducted in a health maintenance
organization (HMO) in southern California that measured the effectiveness of the use of a
telephone protocol on the primary non-adherence (PNA) rate for bisphosphonates. This
study hypothesized that the intervention of a disease management program NP care
manager who used a telephone outreach information technology (IT)-based tool on a
population of patients with a first time prescription for a bisphosphonate would have an
effect on improving the primary non adherence (PNA) rate. A total of 216 male and
female patients enrolled in the study who were 55 years or older.
This intervention was completed by using a computer program known to the
organization as the Knowledge Builder Tool (KBT). The KBT was used to capture
patient data including new prescriptions and tracked those prescriptions for patients who
did not pick up their new prescription bisphosphonate medication during a period of 60
days. In this study, at 14 days, an intervention in the form of a telephone outreach
encounter was performed by the NP care manager of the fracture liaison program. The
following paragraphs describe details of how this study was evaluated, what evidencebased measures were applied to the plan, what instruments or measures were used for
each objective, and what method of analysis was used to measure each objective. The
variable of patients who picked up their medications prior to 14 days and then from 14
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days to 60 days was tracked and compared to determine if a statistical significance
occurred as a result of the program action and not purely by chance..
Searching for patient data is very time consuming for the NP and not a costefficient way for a provider to spend time (Akesson et al., 2013). Without an
appropriately integrated system in place, the NP could spend valuable program time
searching for data to generate appointments and to communicate with the patients. The
KBT assisted with this by generating patient information to the NP on a daily basis. This
time saving feature allowed the NP to receive the list of patients with whom she could
intervene related to their PNA actions in a timely and accurate manner.
The NP started this study on December 8, 2014 following Institutional Review
Board (IRB) approval from the University of Northern Colorado. The study
implemented a protocol in the form of a telephone outreach tool and evaluated the
effectiveness of the protocol on primary non-adherence (PNA) of patients with
osteoporosis over a two month period.
Exclusion Criteria
Patients were excluded from the study if they
•

were younger than 55 years of age

•

had chronic kidney disease (CKD) 4, 5, or were on dialysis

•

had a history of a previous prescription for a bisphosphonate that was picked
up

•

did not have a current organization membership or current pharmacy benefit

•

had filled their prescription in an outside pharmacy

•

had the medication discontinued or placed on hold
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•

had allergies to bisphosphonate medication

•

had any medical contraindication to taking a bisphosphonate

•

died or lost eligibility for the organization membership at any time.
Measureable Objectives

Two objectives were identified in this study:

1.

To develop and test a protocol to identify patients with osteoporosis or at
risk for hip fracture with a new prescription for a bisphosphonate who had
not picked up their medication from the pharmacy.

2.

To lower the primary non–adherence rate to bisphosphonate medication by
20%.

To meet the first objective, the Doctor of Nursing Practice (DNP) student wrote a
protocol for telephone outreach in collaboration with the organization leaders to improve the
incidence of primary non-adherence to a bisphosphonate that was shown to be a prior
problem in this population (see Appendix F for protocol). As the protocol stated, nonadherent patients were called at increments of 14, 28, and 45 days. They were considered

to be PNA at 60 days.
The telephone outreach protocol was used by the NP to apply and to meet the
objectives. The computer sifted through patient data and sent the NP a list of patients for
whom she could apply the telephone outreach tool. The DNP student researcher closely
monitored the NP’s activities and analyzed the performance of the NP in addressing primary
non–adherence (PNA) by using the protocol. The NP met with the DNP student researcher
and the physician advisor on a weekly basis for approximately 20 minutes for a total of 26
meetings. The purpose of all 26 meetings was to verify that all patients were being called on
time, which patients were to be continued in to the next week, and that all steps of the
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protocol were being followed properly. At the end of each week, the physician advisor and
DNP researcher had a telephone meeting to verify patients on the list and who were to be
continued into the next week.
There was no deviation to the study or the protocol at any time. If steps were not
being followed at any time, adjustments in the form, clarification of which patients were still
on the list, and verification that the intake forms were being filled out on time for each call
made were discussed. If a message was left, the intake form was filled out indicating that the
patient was not spoken to but received a reminder message on the answering machine.

The second objective was to lower the primary non–adherence (PNA) rate to
bisphosphonate medication by at least 20%. The rate of PNA was depicted as a
percentage and was compared to the baseline PNA rate of 29.5%. Microsoft Excel
Statistical Tools® was used to determine the rates and percentages that were compared in
this study.
Evidence-based Measures Applied to the
Evaluation Plan
The theory of planned behavior (TPB) was used as a theoretical basis to change
both the NP’s practice behavior and the patients’ behavior to create a new intention to
perform the functions in order to improve PNA. Clinical significance using Chi square
analysis (p value) was determined. Each independent variable was evaluated and
compared for adherence and non-adherence (PNA) properties and their clinical
significance was determined. The connection to the protocol being responsible for
making the change was evidenced by patients’ responses to questions during the
telephone interview and pharmacy data indicating whether or not the patient picked up
the medication after the phone calls were made.
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Effective program evaluation is a systematic way to improve actions and monitor
what has been accomplished. In analyzing and using data to examine the effectiveness
and efficiency of any program, it is important to include a process for continuous quality
improvement to monitor progress and outcomes. The following is a framework designed
to guide health professionals in the process of program evaluation; specifically, this
framework was used in this project to evaluate the telephone outreach protocol. This
evaluation tool was developed by the Centers for Disease Control (2010) and is
comprised of six steps that were used to evaluate the program’s effectiveness (see Figure
4).
1.

Engage stakeholders. The stakeholders were all involved in the protocol
development. They attended frequent face to face meetings and had an
opportunity to give their input. The identified stakeholders in this project
were (a) the DNP student researcher, (b) the MD champion, (c) the HMO
administration, (d) HMO pharmacists, (e) HMO Information Technology
data analysts, (f) Disease Management Program staff, and (g) the patients.

2.

Describe the program. The program is part of a fracture liaison program
(FLS) and was designed to improve the rate of primary non-adherence to a
bisphosphonate medication. The NP coordinated a telephone outreach
service to record patient responses as to the reason they had not picked up
their medication within the allotted 60 days. The NP called each patient on
the list sent to her by a computer system that identified patients who had not
picked up their medication. The NP followed a telephone outreach protocol
and contacted the patients. The goal of the study was to have the patients
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develop an intention to pick up the medication. Using principles of theory
of planned behavior, the NP acted as a change agent to have patients pick up
their medication to patients who prior to the intervention did not pick up
their medication.
3.

Focus on the evaluation design. The focus of this design was to identify the
factors that led to the patient not picking up the medication. The goal of the
NP was to make the patient more aware of the fact that he/she had not
picked up his/her medication to achieve self-efficacy

4.

Gather credible evidence. The literature review discussed the credible and
evidence-based measures used in the paper. Evidence generated by this
study was in the form of data collected during the phone call that was
collected, analyzed, and compared.

5.

Justify conclusions. Proactive program design coordinated by NP using IT
tools was used as an effective method to reduce PNA.

6.

Ensure use and share lessons learned. There were desirable actions that
would lead to an improvement in PNA. Lessons learned from this study
could be generalized to other FLS programs.
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Figure 4. Framework for program evaluation. Source: CDC (1999).

Evaluation of Plan for Dissemination
of Findings
The findings were disseminated within the organization prior to the roll out at all
remaining 12 medical centers in southern California. The plan was to publish the
highlights and the results of this program with the University of Northern Colorado as
well as in a selected medical journal so the results and knowledge gained from this study
could be accessed accurately by the medical community.
Evaluation of Nurse Practitioner Beliefs
About the Theory of Planned Behavior
The theory of planned behavior (TPB) is based on Bandura’s (1977) theory of
self-efficacy. The NP was given information and trained related to self-efficacy and the
importance of TPB to this study. The concepts of TPB such as normative, subjective, and
control beliefs were presented to the NP. The Healthy Bones NP’s beliefs and training
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were evaluated by a questionnaire (see Appendix E). She was asked a series of questions
regarding attitudes and beliefs related to the application of the TPB on the population of
patients in the study in order obtain baseline information of her beliefs before and after
she was exposed to the study information.
Measurement and Evaluation of Patient
and Provider Behavioral Intention and
Behavior Change
The NP enhanced communication with the patient and built trust and rapport
through the telephone conversations (Rogers, 2003). In this study, the NP assessed,
identified, and determined that change was needed in the patient’s behavior. This was
evidenced by whether or not the patient picked up his/her bisphosphonate medication
from the pharmacy on time. The NP utilized her skills in conducting an informational
exchange of information with the patient in the form of a guided telephone call that
helped guide patient decisions (Rogers, 2003). After this step, intention in the patients
was developed that translated into a new behavior. This transition to independence and
change in beliefs and behaviors was due to the intervention and was measured by asking
the patient a series of questions during the telephone interview (Morisky et al., 2008).
To be an effective change agent, it was helpful that the NP believed strongly in what she
was doing and that her actions led to an improvement in the patients’ outcomes. For this
purpose, the NP’s beliefs were measured on a Likert scale in the form of a questionnaire
to determine improvements in her beliefs before and after the in-service of the study was
completed.
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Evaluation of Ongoing Study
Participation
On a weekly basis, the NP, DNP researcher, and physician advisor evaluated
whether or not the data collection forms were being completed and helped to resolve
problems; none were identified (see Appendix I for NP Intake Form). The results of
these meetings were summarized and recorded to insure that the protocol was being
implemented appropriately with each patient enrolled in the study.
Measurement of Patient Behavior
Intention, Behavior Change, and
Measurement and Evaluation of
Outcomes
This study was based on the premise that the patient would develop a change in
intention after receiving the telephone call and then change behavior as the result. This
change was measured as evidenced by the outcomes seen in the responses of the patients
who were called. The data collected were compared to show whether or not they picked
up the medication after they received a reminder call. If the patient was unable to be
contacted, this was noted in the results of how many patients were not actually spoken to
(see Appendix I) but were left messages by the NP. Data collection sheets were used by
the NP to collect data during each telephone call (see Appendix I).
Additional Necessary Resources
The statistical tools used in this study consisted of an initial power analysis to
determine the number of patients needed to determine statistical significance. In this
case, the number of patients enrolled in the population was 216. A Chi square analysis
was used to determine statistical significance of each variable. The descriptive statistics
used were the percentage of patients who were adherent versus the number of patients
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who were primary non adherent (PNA). The percentage of adherent patients was
compared to the percentage of PNA patients. These two groups were comparable
because they all received the same intervention and all met the requirements for study
inclusion. The formula used was as follows:
# of prescriptions picked up/total patients in the study
PNA = 1- adherence.
For example, in the Reynolds et al (2013) study, PNA equaled 1-0.71, which was 29.5%
and 70.5% adherence rates. The same descriptive statistics formulas were used in this
study. In this study, PNA + adherence =1 or 100%. Data analysts from the HMO’s
division of research validated that all results were calculated accurately.
Summary
This protocol was evidence-based and used an existing theoretical framework
based on the belief of changing behavior by creating intention. The protocol used the NP
and the computer to make sure there were no disparities in the way patients were treated.
All patients in the study who did not pick up their medications at 14 days received
telephone calls that asked each patient why he/she had not picked up his/her medication.
Lastly, the data collected and analyzed showed results as a percentage and were
compared to the previous rate of 29.5%, which reflected what existed in the program
when no active steps were in place to reduce PNA, i.e., a protocol. It was hoped this
protocol could be replicated at all of the medical centers within the health plan in which
this study was done and patient outcomes would improve when patients adhered to their
bisphosphonate medication.

CHAPTER IV
RESULTS AND OUTCOMES
This capstone project evaluated the implementation of a newly developed
protocol designed to improve the primary non-adherence (PNA) rate in men and women
55 years of age and older with a first time prescription for a bisphosphonate. The goal
was to improve patient outcomes related to medication adherence by changing his/her
behavior to pick up his/her medication from the pharmacy and to answer the following
research question:
Q1

Will a telephone outreach protocol based on the theory of planned
behavior (TPB) be effective in lowering the primary non-adherence rate
(PNA) to bisphosphonate medication by 20% in a large Health
Maintenance Organization (HMO)?
Objectives of the Study

There were two objectives in this study:
1.

Develop and implement a protocol to target patients diagnosed with or at
risk for osteoporosis and hip fracture who had not picked up their
bisphosphonate medication from the pharmacy within 60 days--primary
non-adherence (PNA).

This objective was met as evidenced by the protocol implemented in this study.
The protocol identified the patients at risk, established the timeline, and was based on
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questions in a theoretical framework (see Appendix F for an example of the telephone
outreach protocol tool).
2.

Decrease the current rate of PNA by at least 20% from the identified rate of
29.5%. The current rate of 29.5% of PNA to bisphosphonate was decreased
by 26.3% to 3.2%. At 14 days during the study, the adherence rate was
87.5% prior to patients receiving a phone call. The PNA rate had been
reduced to 12.5%. This result is further discussed in Chapter V. The results
showed an overall 26.4% absolute reduction and an 89.2% relative
reduction. The goal of a 20% reduction was exceeded.
Study Population

Initially, 224 patients were identified as having a new prescription for a
bisphosphonate and then screened for inclusion into the study. Of the 224 patients, eight
people were excluded, leaving 216 patients who were enrolled and completed the study
(see Table 2 for exclusions). Of the 216 patients, 168 were women (78%) and 48 were
men (22%). The age range of participants was 55-95 years old with an average age of
70.8 years; the standard deviation was 8.9 years. Race was not included in this analysis
because we did not have accurate race data.
The timeframe for recruitment and enrollment of the 216 patients took one month.
Inclusion criteria requirements were all patients 55 years of age and older--both men and
women with a new prescription for a bisphosphonate medication in a large healthcare
system.
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Participant Exclusion
There were several reasons for participant exclusion. Table 2 presents each
reason, the number of patients in each group, and the percentage of each group.

Table 2
Reasons for Participant Exclusion
Reason
Allergy to medication

Number
1

%
12.5

Chronic kidney disease 4/5 or dialysis*

1

12.5

Outside pharmacy**

2

25.0

Skilled nursing facility or hospice***

2

25.0

Medication discontinued

1

12.5

Low Vitamin D or calcium on hold

1

12.5

Total

8

100

*A bisphosphonate is contraindicated in patients in chronic kidney disease.
**Patient used an outside of the facility pharmacy so could not be tracked.
***Patient is confined to home or another facility and would be given their medication by
a nurse
Implementation of the Telephone Protocol
by the Nurse Practitioner
The study began after IRB approval was obtained (see Appendix A). The NP was
oriented to the telephone protocol and she agreed to implement this project on a voluntary
basis. She was administered a questionnaire that investigated her beliefs regarding the
theory of planned behavior (TPB) at the beginning of the study and then two weeks into
the implementation of the study. The questionnaire used a 5-point Likert scale to respond
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to the eight questions: 1—Strongly disagree, 2—Disagree, 3—Neither agree nor
disagree, 4—Agree, and 5—Strongly agree. The results of the questionnaire showed she
scored all 5’s equaling 40. The pre- and posttests revealed no change (see Appendix E).
The NP answered the same on the pre- and posttests with a score of 5 on each question,
showing she was in strong agreement with the study. The purpose of this pre- and
posttest was to serve as a proxy to determine she understood the TPB, agreed with the
concept, and agreed to work with the researcher in conducting the study in addition to the
consents.
The team consisting of the NP, DNP student researcher, and the medical advisor
met on a weekly basis to discuss what had occurred that week and to see if there were any
patients who still needed to be called. The NP was given an opportunity to ask questions
and make clarifications. These meetings occurred during the enrollment period and
throughout the calling period for three months when the study was officially closed--a
total of 14 meetings. The results of the meetings showed they were helpful in keeping
the study on track. The data collection ended earlier than planned because the last
patients refused the medication. In addition, the DNP student and the medical advisor
met each week to discuss enrollment and review the data collected at the end of each
week to see if there were any questions.
The following were highlights of the study plan and flow:
1.

The DNP student researcher, the medical advisor, and the NP care manager
developed a protocol for this telephone outreach tool prior to the proposal
acceptance of this study.
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2.

Telephone outreach was already included in the tasks of the NP care
manager.

3.

Questions in the telephone protocol were developed based on self-efficacy
and the theory of planned behavior (see Appendix F).

4.

After IRB approval was obtained (see Appendix A), patient enrollment
began at the end of 2014.

5.

Weekly meetings occurred during the course of the enrollment and study
period for 14 weeks at which point the study was officially closed.

6.

During the course of the meetings, the study flow was verified and all
telephone calls were tracked.

7.

No problems occurred and any concerns were worked out in weekly
meetings.

8.

Each week, the NP received a list of patients who had received a
prescription for bisphosphonate medication 14 days prior and had not yet
picked up their medication. The NP implemented the protocol with these
patients to impact PNA.

9.

The following unforeseen events occurred as a result of the study and are
described in greater detail in Chapter V:
a.

Two patients picked up medication after 14 days but before the NP
could call them.

b.

Six patients used pharmacies outside of their assigned pharmacy.
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c.

The pharmacy sometimes told patients to come back another day if
they did not have stock or due to other pharmacy workflow concerns.
This number was not known.

The study officially ended 14 weeks after recruitment began when the protocol had been
implemented on all patients enrolled in the study and/or all patients were 60 days out
from receiving their bisphosphonate prescription.
In this study, NP beliefs about TPB were collected by a questionnaire both before
and after the information about TPB was taught to her. There were no changes from the
first time it was completed to the second; she scored the same, all 5s, and her score was
40 on both questionnaires. She knew this study was being planned because of meetings
during the planning phases with the organization. She was very proactive in preparing
for this study as she wanted to end up with good results and report success of the
program. The NP’s beliefs were not being monitored other than to see that she
understood the TPB and was in agreement with the belief of her ability to act as change
agent in the study. The questionnaire served as a proxy to determine she was on board
with the study and she agreed with the concepts being presented.
Telephone Outreach Protocol Tool
The telephone outreach protocol was a tool implemented on 27 patients who were
not adherent in the first 14 days of receiving their bisphosphonate prescription. At 14
days after a patient in the study had not picked up his/her new prescription for a
bisphosphonate, the NP implemented the protocol by placing a phone call to the patient.
Twenty (74%) of 27 patients picked up their medication after receiving one or two phone
calls from the NP who had applied the telephone outreach protocol. Twenty-six calls
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were made to 20 patients in this group for an average of 1.3 calls for each patient. Two
(10%) of these patients in the telephone outreach group picked up the medication after no
calls.
Adherent Group
Overall, the adherence rate in the study was 96.8% (189 + 20 = 209 divided by
216). This represented the adherence rate of the telephone outreach group and nontelephone outreach groups combined (see Tables 3, 4, and 6). The groups were stratified
by age showing results for adherence and PNA after one and two calls. No one in the
adherence group had three calls placed. Two people who did not receive a call picked up
the medication at 17 and 18 days. Although they were included in the telephone call
group, their reasons for not picking up the medications prior to 14 days were not
captured. The following is a breakdown of the calls in the telephone outreach adherent
group: 10 (37%) patients received one call before becoming adherent, 8 (19%) received
two calls before becoming adherent, and 2 (7%) received no call before becoming
adherent.
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Table 3
Adherence Rates Before and After Telephone Outreach Call
Age Group

Picked up Prior Telephone Call
to Day 14
Adherent after
1 call
%
%
N
N

Telephone Call
NonAdherent after 2
Adherent
calls
%
%
N
N

Total

55-59

18

94.7

1

5.3

0

0

0

0

19

60-64

17

85.0

1

5.0

0

0

2

10.0

20

65-69

60

80.0

10

13.3

4

5.3

1

1.3

75

70-74

33

97.1

0

0.0

0

0

1

2.9

34

75-79

23

92.0

1

4.0

1

4

0

0.0

25

80-84

22

88.0

1

4.0

0

0

2

8.0

25

85+

16

88.9

1

5.6

0

0

1

5.6

18

Total

189

87.5

15

7.9

5

2.3

7

3.2

216
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Table 4
Descriptive Statistics of Telephone Outreach Protocol
Average
Age
70.94

Age Range

SD

N

%

55-93

8.9

189

87.5

Picked Up in Telephone
Outreach after Day 14

69.25

55-95

8.3

20

9.3

Picked Up Total

70.80

55-95

8.9

209

96.8

Primary Non-Adherent

72.90

61-88

10.4

7

3.2

Overall

70.85

55-95

8.9

216

100

Picked Up Not in Telephone
Outreach Prior to Day 14
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Table 5
Adherence of Patients
Patient Characteristics

N

%

Average
Age

Age Range

Median
Age

SD

Adherent With No
Telephone Calls Prior to
14 Days after Receiving
Prescription

189

87.5%

70.94

55-93

74

8.9

Adherent After
Receiving 1 or 2
Telephone Calls After
Day 14

20

9.3%

69.25

55-95

75

8.3

Adherent After Receiving
1 Telephone Call After
Day 14

10

4.6%

69.25

55-95

75

8.9

Adherent After Receiving
2 Telephone Calls After
Day 14

8

3.7%

69.25

55-95

75

8.9

Adherent after 0 calls
after Day 14

20

.9%

67

65-69

66

1.5

Total Number of Patients
who were Adherent
following implementation
of protocol

209

96.8%

70.85

55-95

75

8.9

Total of Primary NonAdherent

7

3.2 %

74.5

61-88

74

10.4

All Patients In Study

216

100%

70.85

55-95

74

8.9

Table 6 shows a summarized version of days needed to pick up the call after one
or two calls, if a message was left, or if the patient actually spoke with the patient. A
slight difference was noted; the average age in the group needing one call was 66.3 years
old as opposed to two calls for 72-years-old. The overall age of adherent patients was
69.2-years-old.

Table 6
Adherent Patients Needing a Telephone Call
Number of
calls
needed for
adherent
telephone
outreach
patients

Total
patients

Average
age

sex

Age
range &
Median
age

SD

2 messages
left by NP
Pt
did not
speak to
NP

Spoke
with NP
1st call

Spoke
with NP
on 2nd
call

messages
On 1st call

Message left
on the 2nd
call

Total calls
to 20
patients

Total calls
resulting in
conversation

Total calls
resulting in
messages
left

0

2

73

F

69& 77
Median=
73

5.6yrs

0

0

0

0

0

0

0

0

1

10

66.3

2 (20%)
men
8 women
(80%)

55-81=
Median=
66

6.4yrs

0

7(27%)

0

3

0

10(10x1)

7(27%)

3(12%)

2

8

68.3

2men
(25%)
6 women
(75%)

65-79
Median=

5.2
years

6

0

2

0

6

16 (8x2)

2 (8%)

14(53%)

3

0

0

0

0

0

0

0

0

0

0

0

0

0

Total

20(9.3%

0

4 (20%)
men
16 women
(80%)

0

0

6(23%)

7(27%)

2(8%)

3(12%)

6(23%)

26
(1.3 calls
per person)

9(45%)

17(65%)

Note. Percentages were rounded to nearest number
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Table 7 shows descriptive statistics of one call versus two calls to pick up the
medication in the telephone outreach adherent group.

Table 7
One Call Versus Two Calls to Pick Up Medication in the Telephone Outreach Adherent
Group
Days

N

Average No.
of Days In
Which
Medication
obtained

SD

Men

After First Call

10

2.7

2.1

N
2

After Second Call

8

6.6

6.0

2

No Calls Needed

2

Women

Average
age

%
20

N
8

%
80

66.3

25

6

75

72

2

10

73

Primary Non-Adherent Group
The remaining 7 of the 27 patients (26%) did not up the medication after being
called. Four of the seven patients (57%) stated they did not know her and wanted to wait
until they spoke with their prescribing doctor. Two patients (29%) told the NP on the
first call they forgot; on the second call, they stated they had changed their minds and did
not want the medication due to fear of side effects. One person (14%) who needed a
phone call was not able to be reached by phone and then went on to be PNA after three
messages were left by the NP. Nine calls (35%) resulted in a conversation with the
patient and 17 calls (65%) resulted in messages left. Table 8 provides the origin of the
prescription, reasons for not picking up the medication, whether or not the NP spoke to
the patient, how many calls were made, and how many messages were left.
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Table 8
Reasons for Not Picking Up Medication
Patient

Origin of
Prescription

Reason Given for NonAdherence

Talked to
Patient

Messages
Left

NPCM

Number
of Calls
Made
3

1

Unknown

0

3

2

NPCM

2

Initially said forgot on
first call; now refuses
medication--worried
about side effects

1

1

3

Other

2

Initially said forgot--now
refused on second call.
Worried about
medication side effects
and wants to talk to
prescribing doctor

1—Spoke
on second
call

1

4

Other

1

Refuses treatment--wants
medication discontinued,
has concerns about drug
complications, and does
not think meds are
needed

1

0

5

Other

1

Refused--has concerns
about side effects
Refuses treatment –
Discontinued--concerned
about drug complications

1

0

6

Other

1

Refused--has concerns
about side effects.
Wants to talk to primary
doctor

1

0

7

Other

1

Refused--has concerns
about side effects

1

0

6

5

Talked to
patient vs
message
Total
number of
Calls

Note. NPCM = Nurse Practitioner Case Manager

11
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Characteristics of the Prescriber
Of the 216 patients in the study, 121 (56%) prescriptions were written by the NP
care manager in the program. Of these 121 patients, 14 needed one or two calls by the
NP and 2 (1.7%) went on to be PNA; 105 (87%) picked up their meds in the NP
prescription group prior to 14 days and were included in the overall study adherence
group. Being part of the HMO system, the patients see other physicians who might
generate a prescription for a bisphosphonate and those patients might have been included
in this study. Although the Chi-square analysis was exactly at .054864 and not less than
.05 for the NP writing the prescription and not the primary care provider (MD) or another
outside prescriber, this result was not statistically significant although highly suggestive.
It would be helpful to have the NP write the prescription and call and follow up with
patients.
Ninety-five prescriptions were written by another provider other than the NP. Of
these 95 patients with prescriptions written by someone other than the program NP, five
were in the PNA group and 84 (88.4%) picked up the medication within 14 days and did
not require a phone call. After 14 days, six (6.3%) patients required a phone call and of
these patients, five went on to develop PNA (5.2%). When they were called by the NP,
several gave reasons such as they were afraid of side effects or wanted to talk to their
doctor again. Four patients stated they did not know the NP since she had not written the
prescription; they wanted to speak to their prescribing doctor before they would take the
medication so they refused to pick up the medication. Table 9 provides the prescriber
characteristics for non-adherent patients. Figure 5 shows prescriptions by the nurse
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practitioner versus other clinician for study telephone protocol primary non-adherent
versus adherent groups.

Table 9
Prescriber Characteristics for Non-Adherent Patients
Prescriber

Reason for PNA

Number

NP Case
Manager

Unknown
Fear of side effects
Want to speak to doctor

1
1
N/A

Other

Fear of side effects
Want to speak to doctor

5
5

Total

140
120
100

Average Age of
Patients
66

Media Age
of Patient
67

72.8

74.5

7

121
95

80
NP

60

Other

40
16

20
0

Total

11

Telephone
Protocol

14

6

Adherent

2

5

PNA

Figure 5. Prescriptions by nurse practitioner versus other clinician for study telephone
protocol primary non-adherent versus adherent.
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The first two columns in the chart represent all patients in the study. In the
telephone outreach group, the program NP wrote 121 and 95 prescriptions were written
by another clinician. Results showed that in the NP group, patients were more adherent
and had fewer incidence of PNA than other clinicians. Patients in the NP group appeared
to respond better to the telephone outreach protocol than the prescriptions written for
other clinicians although this was not found to be statistically significant possibly due to
the small sample size.
Table 10 provides the number of prescriptions written by the nurse practitioner,
the number of calls made, the reasons for not picking up the prescription, and messages
left if no contact was made. In the telephone outreach group, the program NP wrote 121
prescriptions. Five (35.7%) of 14 patients in the NP prescriber group answered more
frequently that they forgot and the call served as a reminder. Table 11 shows that 95
prescriptions were written by another clinician; also show, is the number of calls made,
the reason for not picking up the prescription, and messages left if no contact was made.
Five (45%) patients stated they wanted to speak to the prescriber first.
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Table 10
Prescriptions Written by Nurse Practitioner
Total
patients

Percent

Reason for not picking
up prior to 14 days

Could not reach
patient after 3
messages left
1

PNA

2

1.7

1 patient stated on 2nd
call 1 message left
&second call reached
the patient .She stated
initially forgot but now
has decided not to take
the medication - fear of
side effects

Picked up after 1
or 2 calls

18

11.5

Forgot stated will pick
up within the week
Calls or messages left
served as a reminder
for this group.

0

Picked up after no
calls in telephone
outreach group

2

1.65

Patent was on call list
but NP did not get a
chance to call yet. Pt
picked up at 17 and 18
days

0

Picked up prior to
14 days so did not
need a call by NP

105

87

N/A

0

Total

121

100

1
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Table 11
Prescriptions Written by Another Prescriber
Total
Patients

Percent

Reason for not picking up prior
to 14 days

PNA

5

5.2

4 patients wanted to speak to
prescribing doctor first
1 patient had fear of side
effects

Picked up after
1 or 2 calls

6

6.3

2 patients forgot
1 patient was out of the country
3 patients were not contacted

3

Picked up prior 84
to 14 days—did
not need a call
by NP

88.4

N/A

0

Total

100

95

Could not reach
patient after 3
messages left
0

Summary
Of the men and women in the study, 161 women (95.8%) picked up their
medication within 60 days and all 48 men (100%) picked up their medication. The data
analysis showed the Chi square statistic of 2.067 did not reach significance in men versus
women who picked up their medication. The p value was .150519; thus, it was not
significant at p < .05.
A total of 26 calls were made to 20 patients in the study; nine resulted in
conversations with the NP and 17 resulted in a message left. Men were more adherent
than were women in picking up after one message was left: 16 (80%) women vs 4 (20%)
men in the adherent group. The PNA group consisted totally of women.
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The current rate of 29.5% of PNA to bisphosphonate was decreased by 26.3% and
the rate of PNA was reduced from 29.5% to 3.2%. This was a 26.4% absolute reduction
and an 89.2% relative reduction. The goal of a 20% reduction was exceeded; thus, the
two objectives of the study were met.
Figure 6 presents the results from the statistical analyses conducted on the above
three categories.

Figure 6. Results of telephone outreach protocol.

CHAPTER V

DISCUSSION

The goal of any disease management program is to prevent disease from
worsening. The NP-led clinic in this study allowed for patients who had not picked up
their bisphosphonate medication to be identified and tracked more easily than not having
a dedicated person responsible for doing this. The results of this paper showed the
objectives in this study were met. The objectives fit into three levels or categories of
non-adherence: the systems level, the patient level, and the provider level. In addition,
the following research question is discussed:
Q1

Will a telephone outreach protocol based on the theory of planned
behavior (TPB) be effective in lowering the primary non-adherence rate
(PNA) to bisphosphonate medication by 20% in a large Health
Maintenance Organization (HMO)?

The ultimate goal of the program was to lower the PNA rate by targeting those
patients who had not picked up their medication and by changing their behavior to
develop an intention to pick up their medication. The evidence gathered showed the
benefit gained by using the telephone outreach protocol to assist patients in being
adherent in taking their medication. The study results in this paper showed success in
decreasing the PNA rate from 29.5% to 3.2% when the NP used the protocol to facilitate
patient adherence.
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Systems Level
At the systems level in this study, a disease management program setting had the
advantage over other settings because it used a dedicated NP and patients were identified
by using the Knowledge Builder Tool (KBT). The KBT systematically identified nonadherent patients and sent the NP a list of patients who needed a phone call after 14 days
of not picking up the bisphosphonate medication. The telephone outreach tool was used
to implement the prevention intervention strategy to improve patient outcomes. A major
component of the success of this program was it gave the NP the ability to monitor the
treatment of patients using the computer system to follow up and track patient responses.
Using the disease management program telephone outreach protocol allowed the NP to
use a systematic approach when identifying and closing the care gap of PNA. The
systematic approach utilized by the NP insured the intervention was performed uniformly
with each patient receiving the same intervention.
However, it is unclear whether the success of the study was due to the protocol
itself or the message having an effect on patient change in behavior. The integration of
information in this system allowed the NP to focus on calling the patients since the
computer conducted the case finding for her. She applied the protocol to patients who
had not yet picked up their medication at 14, 28, and 45 days. Patients were considered
to be PNA after day 60. If patients in the telephone outreach group did not answer when
the NP called, she left a message to remind the patient to pick up their medication or to
call the department if they had questions. Of the 27 patients in the telephone outreach
group, 20 picked up their medication (74%) following a total of 26 reminder calls. The
other seven patients went on to PNA (26%), yielding a PNA rate of 3.2% for all patients

107
in the study. Of the 26 reminder calls made, 17 resulted in messages left and nine calls
ended in a conversation with the patient in which the protocol was applied. In the
adherent group, 23% of the patients never spoke to the NP and had only messages left
prior to picking up the medication. The messages left might have been be just as
effective in achieving the desired change in behavior as the telephone call or the protocol.
Limited data in this area preclude drawing conclusions and further study in this area is
indicated. In the PNA group (7/27= 25.9%), 11 calls were made to seven patients
resulting in six (55%) conversations with patients and five (45%) messages left. One
person in the PNA group was not reached and three messages were left. For these
patients, a message was not effective in changing behavior. In the PNA group, five of the
seven (71%) received their prescription from a prescriber other than the NPCM and only
two (29%) received their prescriptions from the NPCM. The differences between those
who received the prescription from the NPCM and those who received it from another
prescriber were not statistically significant. Comments made by the patients who
answered that they refused to pick up the medication before making an appointment to
speak with their prescribing doctor suggested clinical differences as they did not pick up
the medication prior to 60 days of the prescription after speaking to the NP.
The findings suggested that had the NP been the prescribing clinician on the
phone with the patient, these patients might have had their questions answered and might
have been persuaded to pick up the medication. Having the prescribing NP call the
patient might be effective as evidenced by four PNA patients’ comments with
prescriptions written by other than the NP coordinator. These patients stated they needed
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to speak with the prescriber again to have questions answered and clarification of side
effects before they decided to pick up the medication.
Provider Level
Overall, this study was successful--the rate of primary non-adherence (PNA) was
lowered, indicating improvement in outcomes for patients. The provider NPCM played a
large role in the success of this study. The rate of PNA went from 29.5% to 12.5% in the
first two weeks of the study. After the first two weeks, a 14 day non-adherence that
began at 87.5% improved to 96.8% by using the telephone outreach tool and leaving
telephone messages reminding patients to pick up their bisphosphonate medication. The
NP’s behavior and communication with patients might have been impacted by the fact
she knew she was being watched/studied (Hawthorne effect; McCambridge, Wilton, &
Elbourne, 2014). This could have been a potential threat to the validity of the study.
Other departments were also aware the study was taking place in the program and
prescribing patterns and PNA were being studied at that facility. The effect of the
expectation of others on changing the NP’s behavior as outlined in TPB could also have
been impacted by the Hawthorne effect (McCambridge et al., 2014) and thus a threat to
validity. Whether or not the patient’s behavior was impacted by the Hawthorne effect
should be considered as well. However, there were inefficient data to say this happened
and should be investigated further to prove this theory. The patients were blinded to the
study so the Hawthorne effect was not a factor in their decisions to change. Since the
bisphosphonate was a normal part of their healthcare, they did not have to sign consents
and were not told their behavior with regard to compliance was being tracked. However,
the TPB may have had an effect on them--the telephone calls and messages made the
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patients aware of an expectation of the organization was they would pick up their
medication. Knowledge of this expectation could have affected them to develop an
intention and carry out the behavior being asked of them.
The TPB states that someone’s behavior might be changed when he/she knows a
behavior is expected of them by others. The TPB was applied here with the protocol but
might also apply in the cases where the NP did not ask the questions, i.e., the telephone
messages left. In 50% of the patient responses in the PNA group, they indicated they had
more questions. The telephone call served as a way for the NP to answer those questions.
The NP’s ability to alleviate patients’ fear of side effects or answer questions about
concerns could increase patients’ feelings of confidence about taking the medication
(social/normative). Additionally, the TPB states that people change their behavior based
on having the belief they are doing the best thing for themselves. Believing one is doing
the best thing for oneself, doing what is expected by others, and the perception of control
to perform the action are three principles of TPB that must be present for behavior
change to occur. The telephone call might serve as an impetus to having those three
concepts present and assist with the behavior change in this way.
Table 5 showed that 8 (40%) of 20 patients who needed a telephone call had one
or two messages left and then picked up the medication without speaking to the NP. This
showed promise that a telephone message might be just as effective as a conversation in
getting patients to pick up the medication. The message might serve as a reminder and
the patient has no questions or reluctance to pick up the medication. However, in the
cases of messages left, there was no patient feedback to be confident of the purpose the
messages served. In other words, not enough data were available to determine how
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effective a message was compared with a conversation using the protocol. Either way,
the time to pick up the medication by patients was reduced after the phone calls were
placed.
The results showed some kind of action was triggered after the call or message
when previous to the call, there was no patient action. The average time to pick up the
medication after the first phone call was 2.7 days; prior to the NP action, the patient had
not picked up the medication after 14 days of the prescription being written. Just the call
itself might have called upon the TPB--the patient, whether speaking to the NP or upon
hearing the message, would realize the organization was expecting an action from
him/her to pick up the medication. Since no data were collected on 17 (65%) of the calls
resulting in messages left and 30% of those patients never actually spoke to the NP, there
is no way to determine the degree of value the messages served when compared to actual
phone conversations.
Patient Level
At the patient level, patients have a responsibility to take their medication and to
work with their healthcare provider to meet their healthcare needs—in this case, lowering
their PNA rate. Patient responses on telephone calls were recorded to know the reasons
why the patients had not picked up their bisphosphonate medication. All of the patients
who were PNA were women. This was shown to be statistically insignificant. Perhaps, it
could be inferred that men might be at less risk for non-adherence when previously they
were thought to be more non-adherent than women.
In this study, the patients participated by responding to the phone calls and
answered questions why they had not picked up their medication prior to 14 days. In four
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out of seven PNA patient responses to the NP on the phone, the patients stated they felt
more comfortable talking to the person who prescribed the medication and they needed to
talk to their doctor before deciding to pick up their medication because they had more
questions. Since the patients stated they did not know the NP caller, they did not feel
comfortable making a decision on the phone with her that day. Having the prescriber of
the medication talk to the patients as follow up when they do not pick up their medication
might be effective. If the caller and the prescriber were one and the same, this barrier to
the patient picking up the medication could have been resolved with the phone call. This
substantiated the argument that the program NP should write the prescriptions for a
bisphosphonate as part of the program and then call patients who did not pick it up. If
contact was not made, it was speculated that a telephone message might be just as
effective as actually speaking with the patient. By responding to the calls, the patients
assisted the study in meeting the goal of lowering the PNA rate.
A majority of the responses by patients were “I forgot” (50%); the telephone
outreach calls might have served as a reminder that taking the medication was important
to the care provider, which fits into the concept in the TPB. The telephone outreach call
could prevent the need for an additional appointment, which could be translated into cost
savings for the patient and the HMO organization. In the private sector, the fee-forservice period of the past is slowly being replaced global billing or one fee for a diagnosis
for a set period of time. It would make sense to conserve face-to-face visits for patients
who really need a visit that cannot be achieved by a phone call or virtual visit. Although
billing and payment were outside of the scope of this study, the HMO does not collect
any additional revenue for face-to-face visits that could easily be handled remotely.
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Timetable to Completion
Enrollment began as soon as the University of Northern Colorado’s Institutional
Review Board (IRB) approval was obtained. Inclusion and exclusion criteria of enrolled
patients was discussed and verified by the medical advisor that each person met criteria
for inclusion/exclusion. The medical advisor and the team met with the Information
Technology Department (IT) to have all patients assigned a unique identifying number so
data presented to the student researcher were blinded from any identifying factors. The
NP started to call patients who met the two week prescription date from November 24,
2014 and applied the protocol to patients meeting the incremental dates of not picking up
their medication from the pharmacy at 14 days and beyond. Weekly meetings were
conducted to troubleshoot and to monitor the course of the study.
Overall, the study flowed well according to the planned timeline. The enrollment
and actual timeline of enrollment took one month; it was predicted to take two months.
When the study began, the providers were prepared to write necessary prescription and
knew that they were being studied. This might have had some effect on the faster rate of
enrollment.
Work Flow Process/Project Activities
The workflow of the study involved the NP working within the disease
management program. She was given a list of patients to call with a new prescription for
a bisphosphonate and then she used the telephone outreach protocol to call the patients at
varied increments of time. The NP was the key player in the success of this study. She
had a physician supervisor and the ability to order a referral to endocrinology services or
to her physician champion for patients needing a specialty consult. She was also the
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primary person who collected the data for the study, which consisted of patient answers
to questions from the telephone outreach protocol. The call, conversation with the
patient, and messages left did not vary in the information provided by the NP and would
have had the same effect on the outcome.
The NP believed she was familiar with the self-efficacy theory (SET) and the
TPB and decided to study these theories on her own as she wanted this program to be a
success. She volunteered to implement this protocol at her program site and had
experience implementing other programs in the past. She was very confident that change
was possible and believed this study would succeed as was stated by her at one of the
meetings while the study was being planned.
The NP called the patient at various intervals of time pre-determined in the
protocol. Using questions designed from the theory of planned behavior (TPB) and the
domains of self-efficacy, the reasons for patient primary non adherence (PNA) and
whether or not the patient changed his/her behavior and picked up his/her medication
were recorded. The protocol targeted patients with primary non-adherence to their
bisphosphonate medication; the goal was to use the protocol to change the patients’
behavior to become adherent to the prescribed bisphosphonate. Although this was a new
tool and was not validated or tested prior to this study, previously published validated
data were used in developing the questions (Ajzen, 1991; Morisky et al., 2009).
However, 17 of the calls in the adherent group ended up with a message being left 23%
of the time; the patients did not actually speak to the NP and picked up the medication
after having two messages left by the NP. This might have prompted the patients to pick
up their medication because the call acted as a reminder, letting the patient know an
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action was expected of them by their healthcare provider. An assumption could be if the
doctor or other healthcare provider thought it was important enough to call several times,
then it must be important and must be taken seriously by the patient. The concepts of
TPB might be applied here even without the administration of the questions that state the
person will change his/her behavior if the action (a) is believed to be beneficial, (b)
behavior change is expected by others, and (c) the behavior is in the perceived control of
the patient. All three of these concepts might have occurred purely by the patient
receiving a call or a message. The expectation of a response by the patient was requested
by the NP either during the telephone call or the telephone message that asked the patient
to please pick up their medication prescription for a bisphosphonate from the pharmacy.
The patients became aware this action was being monitored and was an expected and
desired action by their doctor who was following up on this action.
According to Eisman et al. (2012), using a NP coordinator to make phone calls is
a cost effective way to manage care gaps. As a normal part of her daily activities, the NP
collected the data and communicated with the patients to get feedback that could be used
to improve the goals. Since telephone outreach was already an existing work function for
her, the study did not add more work for her. This study, as indicated by the program,
sparked an interest in future research to evaluate whether or not a phone call might
replace a clinic face-to-face visit to address PNA. Although no time and cost studies
were done in this study, the NP was able to call patients on the phone and save the time
and staff it would take to conduct an office visit. This might be both a time and cost
effective way to close PNA care gaps and should be further investigated.
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Implementation of the telephone outreach program based on TPB was discussed
as a plan to be added to the organization’s strategic goals and implemented organization
wide given the favorable results of this study. However, in cases where the NP did not
speak to the patient directly, no feedback was obtained about the patient’s intention,
leading to insufficient data to determine if the call or message were received by the
patient in the manner intended or if the telephone outreach prompted a response by the
patient. It was assumed some change occurred because 23% of the patients picked up the
medication within 2.7 days after the call; whereas prior to the call, no action had been
taken to pick up the medication greater than 14 days.
Recommendations and Implications for Practice
Primary non-adherence (PNA) has been discussed as being caused by failures at
the patient, provider, or system levels. Literature (Kastner & Straus, 2012) has shown
that successful disease management programs all incorporate the fracture liaison service
(FLS) model of care, telephonic outreach, electronic medical record (EMR), and
integrated pharmacy systems. To date, attempts have been made but no one has been
able to integrate all needed components of this kind of program. This statement gave rise
to the need for further work and research.
The literature has shown that patients with a first time prescription for a
bisphosphonate were not picking up their medications. This problem sparked an interest
to develop a system and protocol that could be applied to improve PNA. Evidence-based
guidelines were ineffective unless they were implemented and then translated into
practice. The implementation of an osteoporosis disease management program,
especially if an electronic health record is used, could be an effective tool in lowering the
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hip fracture rate. Through the use of clinical practice guidelines and a staff trained with
TBP, acceptance and implementation of such systems could facilitate changing current
provider behaviors. The literature did not clarify all factors concerning the reasons for
PNA. Confusion and no standardization of terms and definitions made describing the
problems and solutions difficult to compare between studies. This capstone project
implemented this protocol for which outcomes were measured to determine its
effectiveness in addressing the problem of medication adherence in patients with
osteoporosis. Once this program standardization is established, other researchers can
build upon it instead of recreating and applying new terms to what has already been
established.
The study by Reynolds et al. (2013) was used as a motivator and gave credibility
for the need to implement this program. As a result of this project and success of the
program, the plan is to expand this program to all 13 medical centers in this organization
and employ a NP-led clinic that could easily implement this protocol for patients who had
not picked up their bisphosphonate medication. The computer system is connected to all
sites, centralizing patient chart information; pharmacy data are also connected and easily
tracked. An NP would follow the protocol with those patients who had not picked up
their medication.
It is recommended that this protocol be adopted into practice and integrated into
the organization’s strategic plan. The philosophy of the organization is based on
identifying and then preventing problems known as care gaps using a systems-based
approach to close each care gap. The FLS program has various strategic goals to meet
concerning medication adherence; finding a solution to the problem of PNA could
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become an internal strategic goal of the organization. The NP at the facility would take a
role in training NPs at the other 13 facilities where this protocol would be implemented.
Another recommendation would be to include having the disease management
program NP work more closely with the pharmacy regarding patients who had not picked
up their medications. Mail orders might be adopted in the future to send prescription
medications to patients who are unable to drive to the pharmacy to assure that patients
receive the medication. Additional action by pharmacists would help overcome at least
one barrier to patients receiving their medication as they could encourage the patient to
pick up all of their prescribed medications and send a note back to the prescriber letting
them know when a patient has elected not to pick up all medications and when a
medication has been unfilled for any prolonged period of time. This information could
serve as a future recommendation to include the telephone outreach tool and the
pharmacy to close the care gap of PNA.
Although this program was implemented in a closed system, where the patients
were all members of the health plan and all used the organization’s pharmacies, this type
of program could be implemented in open systems as well. Within any organization, the
computer system would be able to interface with all of the departments and the patient
medical record could be received in real time. The HMO system exemplified in this
organization might offer an advantage to private paying systems. However, it is possible
to implement this in any system where a dedicated person such as an NP could identify,
risk stratify, coordinate the care of the osteoporosis patient, and implement the telephone
outreach program to track patient compliance. It is important that each program maintain
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outcomes information about patients who pick up the medication versus patients who do
not and then use quality measures to continue to improve upon the results.
The literature has shown it is necessary to use a systematic approach and a
dedicated coordinator to close care gaps. It is very time consuming for an NP to search
data to generate appointments for patient encounters or to conduct program outreach
operations. Thus, the KBT could cut down tremendously on the amount of time needed
to track patients. Thousands of records could be sifted by the computer and an updated
list generated on a daily basis, thus allowing the NP to work the list, organize time, and
set priorities more efficiently.
One recommendation for the future would be to automate calls. Call automation
in this organization is currently being performed for other reminders such as scheduling
appointments or diagnostic tests when it is not necessary to speak directly to the patient.
Automated telephone calls to remind patients they should pick their medication could be
made in the voice of the prescriber. By automating the calls, the NP’s schedule could be
freed up to coordinate patient care and follow up needed, further improving time
efficiency and saving money by not paying an employee make the calls. The NP’s time
could also be utilized to answer calls from patients who have questions and have the
machine take a message for patients wishing a return call from their providers. Further
study should be conducted to assess cost effectiveness and cost savings gained from
implementing this protocol, i.e., whether an automated call could be just as effective in
lowering the incidence of PNA as the NP speaking directly to the patient.
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Using an NP as a care coordinator could further the opportunity to meet fracture
reduction goals and improve the rate of PNA. It would be interesting to repeat this study
using more patients to see if differences noted were statistically significant.
In addition, it appeared that even without any action being taken, the PNA rate
could be reduced by having a dedicated person write prescriptions, monitor patient
activity in the program by making phone calls when necessary, and work a list provided
by the computer. In this study, only 37 calls were made, which made a significant
difference in the outcome when compared to what was happening before the outreach
was implemented. On average, it took two calls to have a patient pick up their
medication. These 37 calls were successful in motivating 20 people to pick up their
medication. This left seven patients as PNA compared to the 64 patients (29.5%) seen as
PNA prior to the reduction sparked by the outreach effort. In this study design, the
threshold to meet the reduction goal of this study was set at 50 (20%) people in order to
reduce the PNA rate and meet goals. Having as little as 50 people with PNA in this
study, outcome would have acceptably met the objective of at least a 20% reduction in
objective #2. Instead, this expectation was exceeded and only seven patients were PNA.
Barriers and Unintended Consequences
A few barriers and unintended consequences were encountered during the study.
During the first week of the study, it was difficult to coordinate weekly meetings with the
NP due to her availability but after that, a regularly established day of the week was
scheduled without fail. This weekly meeting was essential to the success of the program
because it clarified communication and kept the study on track. The communication
went as planned as the study progressed. Another perceived barrier quickly overcome
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was the NP reported she could not reach some patients on the phone so she left voicemail
messages. This was accepted into the study and documented as an outcome. Although
the patients still picked up the medication 2.7 days sooner than prior to the call as
compared to 10-14 days with no activity, it is not known what the outcome would have
been if the patients had been reached by the NP. Once the study organization was up to
date on the timeline, the study actually flowed according to plan.
Several unintended consequences were encountered during the study. The first
was not all patients picked up their medications from the medical center pharmacy to
which they were assigned. For example, there were several instances when the patient,
after having surgery for a hip fracture, stayed with family living in the area of another
medical center--the prescription was at one facility but the prescription was picked up in
another area, which delayed the patient from picking up the medication by a week or
more. This situation did not meet the criterion of an outside pharmacy because it was
still within the organization’s pharmacy system and so was able to be tracked. This issue
was not addressed in this study but will be added to future department meetings. There
are plans for the pharmacy to be invited to a monthly meeting so possible solutions to this
problem can be discussed and solutions provided. This was outside the scope of this
project but will be included in the organization’s strategic plan to improve the system and
deal with pharmacy issues.
Another circumstance arose when a patient picked up the medication between 14
and 21 days and might have picked it up prior to receiving the first phone call. This
patient was included in the call group but was also past the first two weeks by a couple of
days and had not yet been called by the NP. Upon chart review, whether or not the
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patient had received a call was clarified, was listed in the results in the call group as zero
calls, and adherent past 14 days. If the patient had not received a call, it was noted that
the patient was adherent upon his/her own accord and was not influenced by the call to
pick up the medication. Two patients met these criteria--they decided to pick up the
medication at 17 and 18 days. Although they were on the call list to be called by the NP,
the NP had not yet called them and they picked up the medication without needing a call.
This could be solved by establishing a more uniformly and systematic method of
implementing timely phones calls.
Still another unforeseen circumstance came when the patients went to the
pharmacy on the day the prescription was written and were told by the pharmacy to come
back another day because the medication was not in stock, back ordered, or the line was
too long and the patient could not wait. Some patients stated they were not able to return
the next day, thus delaying them in getting a ride back to the pharmacy on another day to
pick up the medication if they did not drive. This situation was discussed with the
pharmacy director and the pharmacy has now started a mail order program and is keeping
a larger shelf stock of this particular medication to avoid these problems from reoccurring in the future.
Lastly, the actual rate of PNA had dropped to 12.5% instead of the 29.5% prior to
any intervention beginning. This change might possibly be due the organization knowing
there was a problem. After the NP and the organization were aware they were being
studied, the Hawthorne effect (McCambridege et al., 2014) might have played a role here
as well.
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Framework of the Organization’s Strategic Plan
The contribution of this PNA project was improvement in the overall rate of PNA
in patients with a prescription for a bisphosphonate organization-wide. This protocol
implementation improved the quality of care being delivered and might have saved
money. The outcomes of this study have shown the importance of increasing the
patient’s involvement as a team member in this process. Obtaining their feedback was
invaluable in closing the gap and improving systems to meet organizational goals.
Communication between the patient and the provider can continue to be improved and
the communication path should begin as early as the day the prescription was written. A
verbal contract prior to the prescription being written and verbal acknowledgement that
the patient accepts the prescription being written and is aware of it being sent to the
pharmacy are important steps that should be added to every patient encounter. The
patient must be informed early in the process so he/she can be prepared for what is
expected of him/her. Secondly, a component that should be added is more DXA scan
orders and more diagnoses of osteoporosis or low bone mass so patients can be risk
stratified and counselled. This process of risk stratification could spark a communication
between the provider and the patient and stress the importance of taking the prescribed
medication. These are teaching moments, especially if the patient has already suffered a
fracture and been told how a second fracture could be prevented. Enhanced
communication and acceptance of the protocol or achieving “buy in” from the patient
could surely improve patient adherence to his/her prescribed medications.
This telephone protocol worked well within the organization’s strategic plan
because it used a protocol telephone outreach that was simple and easy to implement.
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This was evidenced by having only one NP manage calls within the program. Human
interaction might be potentially replaced by a computer to call and leave automated
messages. Since many of the patients in the study picked up the medication after
receiving only a message, it might still be effective to leave an automated message.
Patients who wish to speak to a person can opt to leave a message to have someone return
their call.
The telephone outreach approach to closing a PNA care gap could cut down on
the amount of time and staff needed to add face-to-face visits that could be replaced by a
phone call. The telephone encounter was believed to lead to cost savings because it was
carried out by a single NP and used minimal staff time. Although, the actual amount of
time or cost savings was not measured, this needs further study. The results of this study
suggested a telephone message might be just as effective as a telephone conversation as
the average amount of time needed to pick up medication after a telephone call was 2.5
days. Twenty-seven out of 216 patients needed one or more calls. Many of the 20
adherent patients picked up their medication after receiving only a reminder message.
Using a computer instead of a staff person for reminder calls could results in cost savings
provided it was effective. A telephone call could replace clinic time to answer questions
or to follow up on monitoring care or treatments. Since telephone outreach is already a
function of the NP’s normal duties as a care manager, this protocol could be easily
worked into the daily activities of a disease management program coordinator’s duties.
This work as done by NP care managers or possibly a computer could easily be
assimilated into any chronic disease management program to improve outcomes.
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Results not having statistical significance in this study were shown to have
clinical significance and vice versa. For example, two patients picked up the medication
prior to receiving a call. This result had no clinical significance because although they
were not influenced by the call, they went past 14 days and so they were counted in the
call group. Therefore, although they appeared to be PNA, they actually had intention of
picking up the medication and did so without the need for coaching by the NP.
In this study, the NP answered the same on the questionnaire before and after the
implementation of the study. There might have been more opportunity to focus on how
the NP could have augmented conversations with patients to use the TPB more
effectively as it was intended to change patient behavior.
Contribution of the Project to the Attainment
of Personal Leadership Goals
This project was a very important research study in the attainment of the
researcher’s personal goals. This project addressed an interest in practicing in the area of
population disease management, identifying care gaps, and then working to develop
clinical practice guidelines to close those care gaps. Primary non- adherence (PNA) in
the field of osteoporosis disease management is a huge problem that has prevented the
program from attaining its goals and improving patient outcomes. The study results
showed this telephone outreach program worked in one system might also be
implemented in other programs with high non adherence rates. Chronic diseases such as
diabetes and hypertension have no symptoms until the diseases have progressed to
dangerous levels. Patients with asymptomatic chronic diseases such as osteoporosis have
a high risk of PNA. Until the fracture event occurs, many patients do not understand the

125
importance of prevention. Medication in this case could prevent fracture from occurring
50% of the time.
Disease management programs rely heavily on patients taking their medication in
order to prevent the progression of their disease but to date no interventions have
monitored whether or not patients were actually picking up their medication from the
pharmacy and taking it as prescribed. It is extremely rewarding as a healthcare provider
to see patients getting better and to prevent the progression of disease, morbidity, and
mortality. If outcomes in disease management are to be improved, it is important to
understand the patient from his/her viewpoint and include them as a member of the
healthcare team. This study and protocol were intended to include the patient as a team
member and to use communication and feedback to find out the reasons patients did not
take their medication and then intervene appropriately. Historically, this happened 30%
of the time; now it has been shown to be less than 5% and hopefully in the future, it can
be reduced to zero.
How the Project Compares to the Solution
The study goals/objectives were reached as expected quite expediently once the
NP had a protocol and understood the task at hand. The patients who were contacted
were very cooperative. Only a small amount of patients could not be reached or
continued to choose non-adherence despite the multiple attempts by the NP to talk to
them. The project appeared to fit the solution needed. This was evidenced by the
significant decrease in the PNA rate reported. There was an 89.2% decrease in relative
reduction in PNA from the historic PNA rate and the current rate retrieved from the
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study. The chi square for the significance of this occurrence was p < .0001, which means
the reduction seen in this study could not have been by chance.
Summary
It has been two years since the Reynolds et al. (2013) article was published and
the implementation of the telephone outreach solution tool. Acknowledging a problem
and implementing a protocol as a different way of talking to patients or prescribing might
have led to an unconscious improvement in the rate of PNA prior to the study because the
staff knew what was expected of them and the NP knew her actions were being
monitored. This was reflected in the NP questionnaire when she received the same score
on both pre- and post-tests, showing she already had a strong belief in PNA and the
implementation of the study. Her beliefs did not change or improve after the
implantation of the study and remained strong and in full support throughout.
The literature has shown that having a dedicated NP coordinator could reduce the
hip fracture rate and improve outcomes. Using a telephone outreach program, patient and
provider communication would be enhanced and this could translate into better
medication adherence. Waalen et al. (2009) indicated an FLS program using a telephone
outreach protocol to improve medication adherence was slightly better than the general
population. Furthermore, Eisman et al. (2012) determined that having a dedicated
coordinator communicate and coordinate fracture care and treatment translated to cost
savings. A telephone outreach might augment an existing the FLS program to improve
adherence to bisphosphonate medication and enhance communication essential to
improved adherence. This study documented a problem of PNA and used an FLS
program NP and a systems-based approach to close the care gap. It is hoped this study
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could be conducted on a larger scale to further investigate this aspect of the FLS program,
determine the benefits of implementing a telephone outreach protocol based on the
theoretical principle of self-efficacy and TPB, and see whether medication adherence
would improve outcomes and save time and money. Additionally, an automated
telephone outreach systems could free up the coordinator’s time even further to
effectively automate calls to remind patients and let them know an action to pick up their
medication from the pharmacy was expected, thereby increasing opportunities to improve
care through better communication and monitoring of treatment modalities.

REFERENCES
Agency for Healthcare Research and Quality. (2014). Capitated system identifies,
screens, and treats osteoporosis risks, preventing hip fractures, saving lives, and
reducing cost. Retrieved from http://www.innovations.ahrq.gov/content.
aspx?id=2826
Ajzen, I. (1991). The theory of planned behavior: Organizational behavior. Human
Decision Process, 50, 179–211.
Akesson, K., Marsh, D., Mitchell, P. J., McLellan, A. R., Stenmark ,J., Pierroz, D. D.,
…Cooper, C. (2013). Capture the fracture: A best practice framework and global
campaign to break the fragility fracture cycle. Osteoporosis Internationale, 24(8),
2135-52. doi:10.1007/s00198-013-2348-z.
Bandura, A. (1977). Toward a unifying theory of behavioral change. Psychological
Review, 84(2), 191-215.
Bardwell, A., Kushner, P., Malinak J., Lewiecki, M., Greenwald, M., & Rude, R. (2002).
Evidence has suggested that information technology may improve patient
medication adherence to medications. New bone density report format influences
compliance in filling RX for osteoporosis. Clinical Journal of Womens Health, 2,
13-18.

129
Black, D. M., Thompson, D. E., Bauer, D. C., Ensrud, K., Musliner, T., Hochberg, M. C,
…Cummings, S. R. (2000). Fracture risk reduction with alendronate in women
with osteoporosis: The Fracture Intervention Trial (FIT Trial) Journal of Clinical
Endocrinology & Metabolism, 11, 4118-4124.
Bogoch, E., Elliot-Gibson, V., Beaton, D., Jamal, S., Josse, R., & Murray, T. (2006).
Effective initiation of osteoporosis diagnosis and treatment for patients with a
fragility fracture in an orthopaedic environment. Journal of Bone and Joint
Surgery America, 88(1), 25-34.
Boockvar, K. S., Halm, E. A., Litke, A., Silberzweig, S. B., McLaughlin, M., Penrod, J.
D., …Siu, A. L. (2003). Hospital readmissions after hospital discharge for hip
fracture: Surgical and nonsurgical causes and effect on outcomes. Journal of
American Geriatric Society, 51(3), 399-403.
Brown, M., & Bussell, K. (2011) Medication adherence: WHO Cares? Mayo
Clinic Proceeding, 86(4), 304–314. doi:10.4065/mcp.2010.0575
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson,
A. (2007). Incidence and economic burden of osteoporosis-related fractures in the
United States, 2005-2025. Journal of Bone Mineral Research, 3, 465-475.
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P. A.,
& Rubin, H. R. (1999). Why don’t physicians follow clinical practice guidelines?
A framework for improvement. JAMA, 282(15), 1458–1465.
Centers for Disease Control. (1999). Framework for program evaluation in public health.
Morbity and Mortality Weekly Reports, 48, 11. Retrieved from
www.cdc.gov/EVAL/framework/

130
Centers for Disease Control. (2010). The costs of falls among older adults. Retrieved
from http://www.cdc.gov/homeandrecreationalsafety/falls/fallcost.html
Center, J. R., Bliuc, D., Nguyen, T. V., & Eisman, J. A. (2007). Risk of subsequent
fracture after low-trauma fracture in men and women. Journal of the American
Medical Association (JAMA), 24(4), 387-394.
Che, M., Ettinger, B., Johnston, J., Pressman, A., & Liang, J. (2005). Fragile fracture care
management program. Permanente Journal, 9(1), 13–15.
Cheetham, T. C., Niu, F., Green, K., Scott, R. D., Derose, S. F., Vansomphone, S. S,
…Reynolds, K. (2013). Primary nonadherence to statin medications in a managed

care organization. Journal of Managed Care Pharmacy, 9(5), 367-373.
Chinn, P., & Kramer, M. (2010). Integrated theory and knowledge development in
nursing (8th ed.). St.Louis, MO: Mosby.
Compston, J. (2010).Osteoporosis: Social and Economic Impact. Radiologic Clinics of
North America, 48, 477-482.
Cook, P. F. (2008). Patients' and health care practitioners' attributions about adherence
problems as predictors of medication adherence. Research Nursing Health, 31(3),
261-73. doi:10.1002/nur.20256
Cook, P. F., Emiliozzi, S., & McCabe, M. M. (2007). Telephone counseling to improve
osteoporosis treatment adherence: An effectiveness study in community practice
settings. American Journal of Medical Quality, 22(6), 445-456

131
Crum, M. (2012). Mission: Centers for Disease Control Public Health Surveillance and
Informatics Program Division of Informatics Practice, Policy & Coordination.
Retrieved from http://www.cdc.gov/osels/phsipo/dippc/docs/PDF/
Overview%20of%20EHR,%20CDS%20and%20Public%20Health.pdf
Dell, R. (2011). Fracture prevention in Kaiser Permanente Southern California.
Osteoporosis Internationale, 22(Suppl. 3), 457-460.
doi:10.1007/s00198-011-1712-0
Dell, R., & Greene, D. (2010). Is osteoporosis disease management cost effective?
Current Osteoporosis Reports, 8(1), 49-55. doi:10.1007/s11914-010-0009-0
Dell, R. M., Greene, D., Anderson, D., & Williams K. (2009). Osteoporosis disease
management: What every orthopaedic surgeon should know. Journal of Bone
Joint Surgery America, 91(Suppl 6), 79-86. doi:10.2106/JBJS.I.00521
Dell, R., Greene, D., Schelkun, S. R., & Williams, K. (2008). Osteoporosis disease
management: The role of the orthopaedic surgeon. Journal and Bone Joint
Surgery, 4, 188-194. doi:10.2106/JBJS.H.00628.
Dell, R., Loo, R., & Loomis, R. (2012). Case study: Clinical knowledge codification and
invocation framework project: Innovation fund for technology. Retrieved from
https://vine.kp.org/wps/portal/smartbook/home/practice/DSS_tool_IDs_patients_a
t_risk_for_osteop/2012_11_Evidence_0969/Evidence_0969
Drools Guvnor. (n.d.). Retrieved from http://drools.jboss.org/drools-guvnor

132
Eisman, J. A., Bogoch, E. R., Dell, R., Harrington, J. T., McKinney, R. E., Jr., McLellan,
A., & Siris, E. (2012). Making the first fracture the last fracture: ASBMR Task
Force report on secondary fracture prevention. Journal of bone and Mineral
Research, 27, 2039-2046. doi:10.1002/jbmr.1698
Elliott, R. A., & Marriott, J. L. (2009). Standardised assessment of patients' capacity to
manage medications: A systematic review of published instruments. BMC
Geriatrics, 9, 27. doi:10.1186/1471-2318-9-27
Ensrud, K. E., Black, D. M., Palermo, L., Bauer, D. C., Barrett-Connor, E., Quandt, S.
A., …Karpf, D. B. (1997). Treatment with alendronate prevents fractures in
women at highest risk: Results from the Fracture Intervention Trial. Archives of
Internal Medicine, 157, 2617-2624.
Fawcett, J. (2005). Contemporary nursing knowledge: Analysis and evaluation of nursing
models and theories (2nd ed.). Philadelphia: F.A. Davis Co.
Gadkari, A. S., & McHorney, C. A. (2010). Medication nonfulfillment rates and reasons:
Narrative systematic review. Current Medical Research, 26(3), 683-705.
doi: 10.1185/03007990903550586.
Gallagher, T. C., Grelig, O., & Comite, F. (2002). Missed opportunities for prevention of
osteoporotic fracture. Archives of Internal Medicine, 162, 450-456.
Giangregorio, A., Papaioannou, L., Thabane, J., deBeer, A., Cranney, A., Dolovich, L.,
…Adachi, D. (2008). Do patients perceive a link between a fragility fracture and
osteoporosis? BMC Musculoskeletal Disorders, 9, 38.
doi:10.1186/1471-2474-9-38

133
Greene, D., & Dell, R. (2010). Outcomes of an osteoporosis disease-management
program managed by nurse practitioners. Journal of the American Academy of
Nurse Practitioners, 22(6), 326-329. doi:10.1111/j.1745-7599.2010.00515
Greenwald, A. G., & Farnham, S. D. (2000). Using the Implicit Association Test to
measure self-esteem and self-concept. Journal of Personality and Social
Psychology, 79, 1022-1038.
Greenwald, B., Bardwell, A., Malinak, J., Rude, R., Silverman, S. L., & WhiteGreenwald, M. (2002). New bone density report format influences patient
compliance in filling prescriptions for osteoporosis. Clinical Journal Women’s
Health, 2, 13–18.
Grol, R., & Grimshaw, J. (2003, October). From best evidence to best practice: Effective
implementation of change in patients’ care. Lancet, 362(9391), 1225–1230.
Halvorson, G. (2009). Health care will not reform itself: A user's guide to refocusing and
reforming American health care. New York: Taylor and Francis.
Heaney, R. P. (2003). Advances in therapy for osteoporosis. Clinical Medicine &
Research, 1(2), 93-99.
Institute of Medicine. (2006). To err is human: Report and the patient safety literature.
Quality & Safety in Health Care, 15(3), 174–178.
Institute of Medicine. (2010). Crossing the quality chasm, A new health system for the
21st century. Washington, DC: National Academy Press.
Jachna, C. M., & Forbes-Thompson, S. (2005). Osteoporosis: Health beliefs and barriers
to treatment in an assisted living facility. Journal of Gerontological Nursing, 1,
25-30.

134
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008). FRAX and
the assessment of fracture probability in men and women from the UK.
Osteoporosis Internationale, 19(4), 385-97.
Kanter, M., Lindsay, G, Bellows, J., & Chase, A. (2013). Complete care at Kaiser
Permanente: Transforming chronic and preventive care. Joint Commission
Journal of Quality and Patient Safety, 39(11), 484–494.
Kastner, M., & Straus, S. (2009). Clinical decision support tools for osteoporosis disease
management: A systematic review of randomized controlled trials. Journal of
General Internal Medicine, 24(2), 287.
Kastner, M., & Straus, S. (2012). Application of the knowledge to action and medical
research council framework in the development of an osteoporosis clinical
decision support tool. Journal of Clinical Epidemiology, 65, 1163-1170.
Kates, S. L., Blake, D., Bingham, K. W., Kates, O. S., Mendelson, D. A., & Friedman,
S. M. (2010). Comparison of an organized geriatric fracture program to United
States. Geriatric Orthopaedic Surgery and Rehabilitation, 1(1), 15-21.
Kates, S. L., O'Malley, N., Friedman, S., & Mendelson, D. (2012). Barriers to
implementation of an organized geriatric fracture program. Geriatric Orthopaedic
Surgery and Rehabilitation, 3(1), 8-16.
Government Data. Geriatric Orthopaedic Surgery. 2010; 1: 15-21.
Katzan, I., Speck, M., Dopler, C., Urchek, J., Bielawski, K., Dunphy, C., …Parchman, A.
(2011). Electronic health record incentive programs. Retrieved from
http://www.cms.gov/ehrincentiveprograms

135
Lincoln,T., & Builder, C. (1999). Global healthcare and the flux of technology.
International Journal of Medical Informatics, 53(2-3), 213-224.
McCambridge, J., Wilton, J., & Elbourne, D. R. (2014). Systematic review of the
Hawthorne effect: New concepts are needed to study research participation
effects. Journal of Clinical Epidemiology, 67(3), 267–277.
doi: 10.1016/j.jclinepi.2013.08.015
McCormack, J., & Loewen, P. (2007). Adding value to clinical practice guidelines.
Canadian Family Physician, 53, 1326–1327.
McHorney, C. A., Schousboe, J. T, Cline, R. R., & Weiss, T. W. (2008). The
impact of osteoporosis medication beliefs and side-effect experiences on nonadherence to oral bisphosphonates. Erratum in Current Medical Research
Opinions, 23(12), 3137-3152.
McHorney, C., & Spain, V. (2011). Frequency and reasons for medication non
fulfillment and non-persistence amongst American adults with chronic disease in
2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=
Spain%20CV%5Bau%5D&dispmax=50307-20. doi: 10.1111/j.1369-7625.2010.
00619.x. PMID: 20860775.
Marsh, D., Akesson, K., Beaton, D., Bogoch, E., Boonen, S., Brandi, M., …Wahl, D.
(2011). Coordinator–based systems for secondary prevention in fragility fracture
patients. Osteoporosis Internationale, 22(7), 2051-2065.
Melnyk, B. M., & Fineout-Overholt, E. (2011). Evidence-based practice: A guide to
best practice in nursing and healthcare (2nd ed.). Philadelphia, PA: Lippincott
Williams & Wilkins.

136
Mitchell, P. J.(2011). Fracture liaison services: The United Kingdom experience.
Osteoporosis International, 22(3), 487-94.
Mitchell, P. J. (2013). Best practices in secondary fracture prevention: Fracture liaison
services. Current Osteoposis Reports, 11(1), 52-60.
doi: 10.1007/s11914-012-0130-3.
Morisky, D., Ang, A., Krousel-Wood, M., & Ward, H. J. (2009). Predictive validity of a
medication adherence measure in an outpatient setting. Journal of Clinical
Hypertension, 10(5), 348-354.
National Bone Health Alliance. (2013). The 2 million 2 many campaign.
Retrieved from www.nbha.org
National Committee for Quality Assurance (NCQA). (2010). The state of health care
quality: Reform, the quality agenda, and resource use. Retrieved from
http://www.ncqa.org/portals/0/state%20of%20health%20care/2010/sohc%202010
%20-%20full2.pdf.
National Institutes of Health Osteoporosis and Related Bone Diseases-National Resource
Center. (2005). Bone health and osteoporosis: What it means to you. Retrieved
from http://www.niams.nih.gov/Health_Info/Bone/
National Osteoporosis Foundation. (2013a). Clinicians guide to osteoporosis disease
management. Retrieved from http://nof.org
National Osteoporosis Foundation. (2013b). Fast facts. Retrieved from http://www.nof.
org/osteoporosis/diseasefacts.htm

137
Navarro, R. A., Greene, D. F., Burchette, R., Funahashi, T., & Dell, R. (2011).
Minimizing disparities in osteoporosis care of minorities with an electronic
medical record care plan. Clinical Orthopedic Related Research, 469(7), 19311935. doi:10.1007/s11999-011-1852-8
Nayak, S., Roberts, M., & Greenspan, S. L. (2011). Cost-effectiveness of different
screening strategies for osteoporosis in postmenopausal women. Annals of
Internal Medicine, 155(11), 751-761.
doi:10.7326/0003-4819-155-11-201112060-00007
Newman, E. D., Ayoub, W. T., Starkey, R. H, Diehl, J. M., & Wood, G. C. (2003).
Osteoporosis disease management in a rural health care population: Hip fracture
reduction and reduced costs in postmenopausal women after five years.
Osteoporosis Internationale, 14(2), 146-151.
Reynolds, K., Muntner, P., Cheetham, T. C., Harrison, T. N., Morisky, D. E., Silverman,
S., …O'Malley, C. D. (2013). Primary non-adherence to bisphosphonates in an
integrated healthcare setting. Osteoporos Internationale, 24(9), 2509-2517.
doi:10.1007/s00198-013-2326-5.
Rogers, E. (2003). Diffusion of innovations (5th ed.). New York: Free Press.
Sale, J. E., Beaton, D. E., Sujic, R., & Bogoch, E. R. (2010). If it was osteoporosis, I
would have really hurt myself. Ambiguity about osteoporosis and osteoporosis
care despite a screening programme to educate fragility fracture patients. Journal
of Evaluation in Clinical Practice, 16(3), 590-596. doi:10.1111/j

138
Sale, J., Gignac, M., Hawker, G., Frankel, L., Beaton, D., Bogoch, E., & Elliot-Gibson,
V. (2011). Decision to take osteoporosis medication in patients who have had a
fracture and are high risk for future fracture: A qualitative study. Biomedical
Central (BMC) Musculoskeletal Disorders, 12, 92.
doi:10.1186/1471-2474-12-92
Silverman, S. L., & Gold, D. T. (2008). Compliance and persistence with osteoporosis
therapies. Current Rheumatology Reports, 10(2), 118–122.
Silverman, S. L., Schousboe, J. T., & Gold, D. T. (2011). Oral bisphosphonate
compliance and persistence: A matter of choice? Osteoporosis Internationale,
22(1), 21-26. doi: 10.1007/s00198-010-1274-6.
Siris, E. S., Boonen, S., Mitchell, P. J., Bilezikian, J., & Silverman, S. (2012). What's in a
name? What constitutes the clinical diagnosis of osteoporosis? Osteoporosis
Internationale, 23(8), 2093-2097. doi:10.1007/s00198-012-1991-0
Siris, E., Harris, S. T, Rosen, C. J., Barr, C. E., Arvesen, J. N., Abbott, T. A., &
Silversein, S. L. (2006). Adherence to bisphosphonate therapy and fracture rates
in osteoporosis. Mayo Clinic Proceedings, 81(8), 1013-1022.
doi:10.1186/1748-5908-8-68PMCID
Solomon, D., Finkelstein, J., Katz, J., Mogun, H., & Avorn, J. (2003). Underuse of
osteoporosis medications in elderly patients with fractures. American Journal of
Medicine, 115(5), 398–400.

139
Solomon, D., Patrick, A., Schousboe, J., & Losina, E. (2014, January 20). The potential
economic benefits of improved post-fracture care: A cost-effectiveness analysis of
a fracture liaison service in the U.S. health care system. Journal of Bone Mineral
Research. doi: 10.1002/jbmr.2180
U.S. Department of Health and Human Services (DHHS). (2004). The 2004 Surgeon
General's report on bone health and osteoporosis: What it means to you.
Retrieved from http://www.surgeongeneral.gov
Waalen, J., Bruning, A. L., Peters, M. J., & Blau, E. M. (2009). A telephone-based
intervention for increasing the use of osteoporosis medication: A randomized
controlled trial. American Journal of Managed Care, 15, e60–70.

APPENDIX A
UNIVERSITY OF NORTHERN COLORADO
INSTITUTIONAL REVIEW BOARD
APPROVAL

141

APPENDIX B
CONSENT FORM FOR HUMAN PARTICIPANTS
IN RESEARCH

143

CONSENT FORM FOR HUMAN PARTICIPANTS IN RESEARCH
UNIVERSITY OF NORTHERN COLORADO
Project Title: Addressing Adherence to Bisphosphonate Medication Using a Systems –
based Approach
Researchers: Denise Greene, NP, Gloria Dominguez NP, Richard Dell MD
Phone: 323-376-9418 denisgreene10@gmail.com; Richard.M.Dell@kp.org
Contact person for concerns about treatment of research subjects or selection process
Please contact Sherry May IRB Administrator Office of Sponsored Programs
Kepper Hall University of Northern Colorado
Sherry.May@unco.edu 970-351-1910
Purpose and Description of project: The primary purpose of this study is to determine
the effectiveness of using a systems-based approach and a telephone outreach
questionnaire to improve patient non adherence to bisphosphonate medication.
It is a population based study that will involve having a Nurse Practitioner call patients
who have not picked up their bisphosphonate medication from the pharmacy within 60
days of the prescription.
Risks are minimal and may involve minor annoyance or feeling anxious to have to talk
on the phone with your healthcare provider about the prescription bisphosphonate
medication that has been written for you and that you have not picked up. Additional
benefit to you is that you will receive information and access to have questions answered
that will help to decrease your fracture risk. You will gain the benefit of the medication
should you decide to pick it up from the pharmacy and the questionnaire may act as a
reminder to you to do so, in case you may have forgotten to pick it up. You will have the
opportunity to ask questions and have extra access to your health care provider to have
any questions answered completely.
Participation in this phone call is voluntary. You have the right to refuse to participate.
Your decision will be respected. No consequence will come to you should you decide to
not engage in this call. All information given is kept confidential. Answering these
questions will be consent for your participation in this telephone outreach call. Do you
give me consent to ask you the following questions about your prescription medication?
I ________________________am giving consent to participate in this research study. I
will be following and maintain all rules of confidentiality and protection of human rights
as I understand according to HIPAA and the policy and procedure manual of my
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organization. I understand that participation is voluntary and I can withdraw at any time. I
agree that I will not share any information about this study outside of the organization
and outside of the communication with the researchers directly involved. I can retain a
copy of this consent for my own records. I have been given an opportunity to ask
questions. I have the contact information of my co- researchers available to me and I
know that I am free to contact them at any time.
Should you have any additional concerns about the treatment or selection of patients for
this study please contact: Sherry May IRB coordinator at the University of Northern
Colorado Office of Sponsored Programs- Kepner Hall, Greeley Colorado 80638 tel:
(970)351-1910
Signature____________________________________

Date___________________________
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Statement of Mutual Agreement
University of Northern Colorado
Doctorate of Nursing Practice Capstone Project
Denise Greene
August 5, 2014
The purpose of the “Statement of Mutual Agreement” is the shared vision between
Denise Greene and the Kaiser Permanente Healthy Bones Program to improve the care
and outcomes of patients in the Healthy Bones Program. The vision is to use the program
protocol and technology to improve the rate of patients to pick up their prescribed
bisphosphonate medications from the pharmacy.
Proposed Project Title:
Addressing Adherence to Bisphosphonate Medication Using a Systems-Based Approach
Brief Description of Proposed Project:
Implementing a protocol and a systems-based approach to improve patient adherence to
first time prescription to a bisphosphonate medication. The protocol uses the theoretical
framework of the Theory of Planned Behavior (TPB) and telephone outreach by a nurse
practitioner.
Goal of Capstone Project :
The goal of the project is to improve primary adherence of patients who have been
prescribed a bisphosphonate medication by 20% within 60 days of the date of the
prescription.
Proposed On-site Activities:
The Healthy Bones Care Manager Nurse Practitioner (NP) will work within the existing
program to screen patients with a protocol and telephone outreach program to lower the
current rate of primary non adherence to a bisphosphonate. The program is designed to
facilitate a change in patient intention and behavior using a theoretical framework and a
systems based approach. The patients will pick up their bisphosphonate medications from
the pharmacy.
Confidentiality of Patient Records: (If applicable)
Confidentiality of patient records will be maintained using internal Kaiser Permanente
Healthy Bones Program policies and HIPAA.
The designated Capstone Community/Agency member will agree to participate in the
review and approval of the proposal and presentation of the final version of the project.
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He/she will attend both on campus or remotely. The student researcher will have no
contact with patients.
The DNP Capstone project will include a final report, an abstract, potential publication or
oral presentation of the report. No personal identifiers will be included and all data will
be reported in aggregate form. The author welcomes any comments or suggestions from
the Agency, but reserves the right to publish findings and analysis according to
professional standards and principles of academic freedom. For any work of a scholarly
nature, the Author agrees to follow the Agency preferences in how it is to be named (or
not) in the work.
Denise Greene_________________________________________________August 3, 2014
Signature of Student
Date
____λ_________________________________________8-5-14
Signature of Agency Member
Date
____Yvonne Yousey , RN, PhD._________________________8-9-2014
Signature of Capstone Chair
Date
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The purpose of this questionnaire is to elicit feedback from the NP regarding her
understanding that there is a problem of PNA before and after her in-service and to gauge
her beliefs of the possibility of arriving at a solution to PNA by using the protocol. You
are being asked to rank your responses on a scale of 1-6 of your beliefs before and after
the study. Please circle your response and sign the bottom.
1.

How much of a problem do you believe PNA poses in your patient population?
Please circle 1--no relationship to 6--extreme positive relationship
Before
After

2.

1
1

2
2

3
3

4
4

5
5

6
6

Do you believe you can play a role to improve the rate of PNA using the
protocol?
Please circle 1--no relationship to 6--extreme positive relationship
Before
After

3.

1
1

2
2

3
3

4
4

5
5

6
6

How important of a role does patient input play in the process of improving PNA?
Please circle 1--no relationship to 6--extreme positive relationship
Before
After

4.

1
1

2
2

3
3

4
4

5
5

6
6

Do you believe you understand what is PNA?
Please circle 1--no relationship to 6--extreme positive relationship
Before
After

1
1

2
2

3
3

4
4

5
5

6
6
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Normative/Subjective Belief
An individual's perception about the particular behavior is influenced somewhat
by the judgment of significant others. The individual NP’s perception of social
normative pressures and relevant others' beliefs that he or she should or should not
perform such behavior. In this case normative behavior will be affected by what the NP
believes her peers will think of her and what is in her scope as an NP. Behavior that is
influenced by the judgment of significant others or others with influence or others such as
managers. Such as in this case, the NP is influenced by the telephone protocol steps and
the desires of her manager to implement the protocol.
5.

What are your beliefs about your normative/subjective belief in this study?
Please rank that you are influenced by what is expected of you by others.
Please circle 1 = no influence to 6 = extreme influence
Before
After

1
1

2
2

3
3

4
4

5
5

6
6

Control Beliefs /Perceived Behavioral Control
An individual's perceived ease or difficulty of performing the particular behavior
(Ajzen, 1991). It is assumed that perceived behavioral control is determined by the total
set of accessible control beliefs. In this case, the NP needs to believe she has control of
the environment and will positively influence each individual patient with whom she
interacts.
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6.

What are your beliefs about your behavioral control beliefs in this study?
Please circle 1 = no influence to 6 = extreme influence
Before
After

1
1

2
2

3
3

4
4

5
5

6
6
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Below is an evaluation checklist to be done by the DNP student for each patient enrolled
in the study and contacted by the NP.
NP Evaluation Checklist
NP Evaluation form date
Provider--who wrote the
prescription
Name of patient
Medical Record #
Comments made by Care
Manager
Sex
Age
Medication
Date Ordered
Last DXA
Tscore
Hx AFF (Exclude if yes)
Last FX
Last FX Date
LTC/SNF/Hospice (Exclude
if yes)
Allergy (Exclude if allergy
BP)
Last CKD (Exclude if CKD
4,5 or Dialysis)
Last CKD Date
Dx Exclusion
Dx ExclusionDate
Reclast Date (Exclude if last
Reclast within 1 year)
Home Phone
Work Phone
Med Center
Meds written to pick up
outside Kaiser - excluded

14 days

30 days 45 days

60 days

Comment
s
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Patient Evaluation of Responses During Telephone Outreach
Question

Domain of Adherence

Theory of Planned
Behavior

Patient Responses

The system shows that you have
not picked up your antiosteoporosis medication from the
pharmacy. Are you aware of this
prescription?

Knowledge

Is there a reason you did not pick
up the medication?

Attitude

Yes/no
If yes state reason

Do you believe that you need this
medication?

Attitude

Yes/no

Are you satisfied with your doctor
visit experience and the
instructions given to you about the
medication?

Satisfaction, knowledge

Social

Yes/no

Do you have family and other
support to help you with bone
health issues?

Social support

Social

Yes/no

Taking medications regularly is a
hassle to some people. Do you
feel that taking your medication is
too inconvenient or too complex?

Medication complexity

Subjective

Yes/ no

Do you have concerns such as
fear of taking this specific
medication?
If yes state the fear.

Stress

Perceived Control

Yes/no

Do you sometimes feel like you
don’t want to take your
medication because you don’t
believe that you

Coping

Subjective

Yes/ no

Do you plan to pick up the within
the next week?

Developing intention

Control

Yes/no

Was this call instrumental in
helping you to decide to pick up
your medication?

Developing intention

Yes/no

Was this call helpful in answering
all of your questions?

Developing intention

Yes/no

Yes/no
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Telephone Outreach Protocol
Do you give me consent to ask you questions about your prescription medication?
Questions
1).The system shows that you have not picked up your antiosteoporosis medication from the pharmacy. Are you aware of this
prescription? Level of intention to pick up
2)Is there a reason that you did not pick up the medication? State the reason
3) Do you believe that you need this medication?
4).Are you satisfied with your doctor visit experience and instructions given
to you about the medication
5Do you have family or other support to help you with bone health issues?
6) Taking medications regularly is a hassle to some people. Do you feel that
taking medication is too inconvenient or complex?
7) Do you have concerns such as fear of taking this specific medication?
8) Do you sometimes feel like you don’t want to take your medication
because you don’t believe you need it?
9). Do you plan to pick up the medication within the next week?
10). Was this call instrumental in helping you to develop a new intention to
pick up the medication?
11). Was this call helpful in answering all of your questions?

Yes/No

APPENDIX G
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Dear Ms. Test Patient,
This past week you were diagnosed with osteoporosis, which means you are at
an increased risk for having a fracture or broken bone with a simple fall or
minor accident. As I reviewed your health records, I noticed you have not filled
your prescription to treat your osteoporosis with Alendronate. This medication
reverses bone loss, strengthens bones, and prevents fractures and is usually
taken for at least five years.
Please fill this prescription as soon as possible. When your prescription runs
out, you may request a refill by calling the pharmacy. If you have any concerns
regarding treatment with this medication or if you have any questions
regarding your osteoporosis, please do not hesitate to call me.
Sincerely,

Healthy Bones Team NP Care Manager

APPENDIX H
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NP Intake Form/Patient Feedback

Patient Identifying Number______________________________
MR#___________________________________
Date of Rx______________________________
Date of call____________________________
Sequence in the process/protocol of calls :
Circle one :
14 day,
30 day,
45 day,
60+ days since patient has picked up medication
Did call go to voicemail? Y / N
Left message to call back Y / N
Patient Reason for not picking up the medication________________________________
_______________________________________________________________________
_______________________________________________________________________
Plan for follow up: __________________________________________________
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Summary of Patient Responses
Patient Population
N=216

Adherent %
N=

PNA%
N=

Pvalue=

Independent
variable
Age
55-64

Number Adherent

Number PNA

Pvalue=

65-74
75-84
85+
Sex=Men
Sex= Women
Characteristics of
Prescriber
NP
MD
Other

